1-Pentanone, 5-methoxy-1-[4-(trifluoromethyl)phenyl]-,O-(2-aminoethyl)oxime, (1E)-
| Title | Journal |
|---|---|
| Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibition by Optimization of the 2-Aminopyridine-Based Scaffold with a Pyridine Linker. | Journal of medicinal chemistry 20160526 |
| Effects of selective serotonin reuptake inhibitors on three sex steroids in two versions of the aromatase enzyme inhibition assay and in the H295R cell assay. | Toxicology in vitro : an international journal published in association with BIBRA 20151001 |
| Fluvoxamine by itself has potential to directly induce long QT syndrome at supra-therapeutic concentrations. | The Journal of toxicological sciences 20150201 |
| GTP cyclohydrolase 1 gene haplotypes as predictors of SSRI response in Japanese patients with major depressive disorder. | Journal of affective disorders 20121215 |
| Involvement of the sigma1 receptor in the antidepressant-like effects of fluvoxamine in the forced swimming test in comparison with the effects elicited by paroxetine. | European journal of pharmacology 20121205 |
| Acute and sustained effects of a metabotropic glutamate 5 receptor antagonist in the novelty-suppressed feeding test. | Behavioural brain research 20121201 |
| In silico and intuitive predictions of CYP46A1 inhibition by marketed drugs with subsequent enzyme crystallization in complex with fluvoxamine. | Molecular pharmacology 20121101 |
| Acute treatment with fluvoxamine elevates rat brain serotonin synthesis in some terminal regions: an autoradiographic study. | Nuclear medicine and biology 20121001 |
| Granisetron adjunct to fluvoxamine for moderate to severe obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial. | CNS drugs 20121001 |
| A randomized, double-blind, placebo-controlled trial of fluvoxamine in patients with schizophrenia: a preliminary study. | Journal of clinical psychopharmacology 20121001 |
| Duloxetine-associated tardive dyskinesia resolved with fluvoxamine: a case report. | Journal of clinical psychopharmacology 20121001 |
| Sigma-1 receptor agonist fluvoxamine for delirium in older adults. | International journal of geriatric psychiatry 20120901 |
| Metabolism of the active metabolite of quetiapine, N-desalkylquetiapine in vitro. | Drug metabolism and disposition: the biological fate of chemicals 20120901 |
| Sertraline treatment of patients with major depressive disorder who failed initial treatment with paroxetine or fluvoxamine. | Progress in neuro-psychopharmacology & biological psychiatry 20120807 |
| Behavioural and pharmacological effects of fluvoxamine on decision-making in food patches and the inter-temporal choices of domestic chicks. | Behavioural brain research 20120801 |
| Treatment practices in Tourette syndrome: the European perspective. | European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 20120701 |
| Pharmacokinetics and distribution of fluvoxamine to the brain in rats under oxidative stress. | Free radical research 20120701 |
| Plasma fluvoxamine levels and OCD symptoms/response in adult patients. | Human psychopharmacology 20120701 |
| Thiophene bioisosteres of spirocyclic σ receptor ligands: relationships between substitution pattern and σ receptor affinity. | Journal of medicinal chemistry 20120614 |
| Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. | Journal of medicinal chemistry 20120524 |
| Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity. | Drug metabolism and disposition: the biological fate of chemicals 20120501 |
| Can Minnesota Multiphasic Personality Inventory-2 predict response to selective serotonin reuptake inhibitors in depressed outpatients? | International clinical psychopharmacology 20120501 |
| Stereoselective metabolism of tetrahydropalmatine enantiomers in rat liver microsomes. | Chirality 20120501 |
| Involvement of P-glycoprotein and cytochrome P450 3A in the metabolism of florfenicol of rabbits. | Journal of veterinary pharmacology and therapeutics 20120401 |
| The potency of fluvoxamine to reduce ethanol self-administration decreases with concurrent availability of food. | Behavioural pharmacology 20120401 |
| Comparison of the effects of estradiol and progesterone on serotonergic function. | Biological psychiatry 20120401 |
| Fluvoxamine increased glutamate release by activating both 5-HT(3) and sigma-1 receptors in prelimbic cortex of chronic restraint stress C57BL/6 mice. | Biochimica et biophysica acta 20120401 |
| Predicting drug candidate victims of drug-drug interactions, using microdosing. | Clinical pharmacokinetics 20120401 |
| Different effects of the selective serotonin reuptake inhibitors fluvoxamine, paroxetine, and sertraline on the pharmacokinetics of fexofenadine in healthy volunteers. | Journal of clinical psychopharmacology 20120401 |
| [JSNP Excellent Presentation Award for AsCNP 2011: involvement of 5-HT(1A) receptors in fluvoxamine-induced enhancement of prefrontal dopamine release]. | Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20120401 |
| Comparison of effects of a selective 5-HT reuptake inhibitor versus a 5-HT4 receptor agonist on in vivo neurogenesis at the rectal anastomosis in rats. | American journal of physiology. Gastrointestinal and liver physiology 20120315 |
| Mechanisms of action of selective serotonin reuptake inhibitors in Daphnia magna. | Environmental science & technology 20120306 |
| Clinical impact of fluvoxamine-mediated long QTU syndrome. | European journal of clinical pharmacology 20120101 |
| The relationship between clinical pharmacokinetics of aripiprazole and CYP2D6 genetic polymorphism: effects of CYP enzyme inhibition by coadministration of paroxetine or fluvoxamine. | European journal of clinical pharmacology 20120101 |
| Decreased brain sigma-1 receptor contributes to the relationship between heart failure and depression. | Cardiovascular research 20120101 |
| Effect of fluvoxamine on the pharmokinetics of zolpidem: a two-treatment period study in healthy volunteers. | Clinical and experimental pharmacology & physiology 20120101 |
| Sudden gains in the treatment of obsessive-compulsive disorder. | Psychotherapy and psychosomatics 20120101 |
| [Cardioprotective effect of fluvoxamine, sigma-1 receptor high affinity agonist]. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20120101 |
| Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions. | Current medicinal chemistry 20120101 |
| N-acetyl-L-cysteine inhibits marble-burying behavior in mice. | Journal of pharmacological sciences 20120101 |
| A preliminary study of fluvoxamine maleate on depressive state and serum melatonin levels in patients after cerebral infarction. | Internal medicine (Tokyo, Japan) 20120101 |
| Cognitive therapy versus fluvoxamine as a second-step treatment in obsessive-compulsive disorder nonresponsive to first-step behavior therapy. | Psychotherapy and psychosomatics 20120101 |
| Differences between mice strains in response to paroxetine in the forced swimming test: involvement of serotonergic or noradrenergic systems. | European journal of pharmacology 20111215 |
| 2D-3D shape reconstruction of the distal femur from stereo X-ray imaging using statistical shape models. | Medical image analysis 20111201 |
| The impact of depression on the treatment of obsessive-compulsive disorder: results from a 5-year follow-up. | Journal of affective disorders 20111201 |
| Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). | PLoS computational biology 20111201 |
| [First death case of serotonin syndrome in Japan induced by fluvoxamine and tandospirone]. | Chudoku kenkyu : Chudoku Kenkyukai jun kikanshi = The Japanese journal of toxicology 20111201 |
| [Effects of smoking and caffeine on pharmacological treatment for patients with schizophrenia and depression]. | Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence 20111201 |
| Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20111108 |
| Selective serotonin re-uptake inhibiting antidepressants and the risk of overanticoagulation during acenocoumarol maintenance treatment. | British journal of clinical pharmacology 20111101 |
| Augmentative effects of fluvoxamine on duloxetine plasma levels in depressed patients. | Pharmacopsychiatry 20111101 |
| The triple reuptake inhibitor DOV216,303 exhibits limited antidepressant-like properties in the differential reinforcement of low-rate 72-second responding assay, likely due to dopamine reuptake inhibition. | Journal of psychopharmacology (Oxford, England) 20111001 |
| Fluvoxamine enhances prefrontal dopaminergic neurotransmission in adrenalectomized/castrated mice via both 5-HT reuptake inhibition and σ(1) receptor activation. | Psychopharmacology 20111001 |
| Differences between early and late drop-outs from treatment for obsessive-compulsive disorder. | Journal of anxiety disorders 20111001 |
| 5-HT(1A) receptor sensitivity in 5-HT(1B) receptor KO mice is unaffected by chronic fluvoxamine treatment. | European journal of pharmacology 20110930 |
| Possible association between ubiquitin-specific peptidase 46 gene and major depressive disorders in the Japanese population. | Journal of affective disorders 20110901 |
| Impact of sample hemolysis on drug stability in regulated bioanalysis. | Bioanalysis 20110901 |
| Clinical study on the efficacy of fluvoxamine for psychological distress in gynecologic cancer patients. | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20110801 |
| A case of pervasive developmental disorder complicated by social anxiety disorder responding well to fluvoxamine therapy. | The Tokai journal of experimental and clinical medicine 20110720 |
| CYP2D6 genotype and smoking influence fluvoxamine steady-state concentration in Japanese psychiatric patients: lessons for genotype-phenotype association study design in translational pharmacogenetics. | Journal of psychopharmacology (Oxford, England) 20110701 |
| Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk. | Cardiovascular research 20110701 |
| Species independence in brain tissue binding using brain homogenates. | Drug metabolism and disposition: the biological fate of chemicals 20110701 |
| SSRI augmentation of antipsychotic alters expression of GABA(A) receptor and related genes in PMC of schizophrenia patients. | The international journal of neuropsychopharmacology 20110601 |
| Long-term follow-up of hypochondriasis after selective serotonin reuptake inhibitor treatment. | Journal of clinical psychopharmacology 20110601 |
| A rapid, Web-based method for obtaining patient views on effects and side-effects of antidepressants. | Journal of affective disorders 20110401 |
| The involvement of GABA(A) receptor in the molecular mechanisms of combined selective serotonin reuptake inhibitor-antipsychotic treatment. | The international journal of neuropsychopharmacology 20110301 |
| Clinical usefulness of limited sampling strategies for estimating AUC of proton pump inhibitors. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20110301 |
| Symptoms of agitated depression and/or akathisia. | Psychiatria Danubina 20110301 |
| Beneficial effects of fluvoxamine for hemiballism in a patient with depressive disorder: a case report. | Acta neurologica Belgica 20110301 |
| Automated experimental system capturing three behavioral components during murine forced swim test. | Life sciences 20110227 |
| Euprolactinemic gynecomastia and galactorrhea with risperidone-fluvoxamine combination. | Psychopharmacology bulletin 20110215 |
| Neonatal exposure to fluoxetine and fluvoxamine alteres spine density in mouse hippocampal CA1 pyramidal neurons. | International journal of clinical and experimental pathology 20110201 |
| Effect of glibenclamide on antinociceptive effects of antidepressants of different classes. | Clinics (Sao Paulo, Brazil) 20110201 |
| Sigma-1 receptor stimulation with fluvoxamine activates Akt-eNOS signaling in the thoracic aorta of ovariectomized rats with abdominal aortic banding. | European journal of pharmacology 20110115 |
| Lithium addition to a tricyclic antidepressant results in optimal efficacy. | Acta psychiatrica Scandinavica 20110101 |
| Misdiagnosis and exacerbation of unusual obsessive-compulsive disorder presentation with risperidone and clozapine in an adolescent girl - A case report. | Collegium antropologicum 20110101 |
| Decrease in brain distribution of fluvoxamine in experimental hyperlipidemic rats. | Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20110101 |
| Effects of PB190 and PB212, new σ receptor ligands, on glucocorticoid receptor-mediated gene transcription in LMCAT cells. | Pharmacological reports : PR 20110101 |
| [Serotoninergic mediator system in the pathogenesis and treatment of idiopathic generalized epilepsy]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20110101 |
| Chronic catatonia with obsessive compulsive disorder symptoms treated with lorazepam, memantine, aripiprazole, fluvoxamine and neurosurgery. | BMJ case reports 20110101 |
| Effect of catechol-O-methyltransferase Val(108/158)Met polymorphism on antidepressant efficacy of fluvoxamine. | European psychiatry : the journal of the Association of European Psychiatrists 20101201 |
| A predictive ligand-based Bayesian model for human drug-induced liver injury. | Drug metabolism and disposition: the biological fate of chemicals 20101201 |
| Sertraline increases extracellular levels not only of serotonin, but also of dopamine in the nucleus accumbens and striatum of rats. | European journal of pharmacology 20101125 |
| Sigma1-receptor stimulation with fluvoxamine ameliorates transverse aortic constriction-induced myocardial hypertrophy and dysfunction in mice. | American journal of physiology. Heart and circulatory physiology 20101101 |
| Differences in clinical effect and tolerance between fluvoxamine and paroxetine: a switching study in patients with depression. | Human psychopharmacology 20101101 |
| Schizophrenia and obsessive-compulsive disorder. | The American journal of psychiatry 20101101 |
| Fluvoxamine improved cognitive impairments in a patient with schizophrenia. | Progress in neuro-psychopharmacology & biological psychiatry 20101001 |
| Targeting sigma-1 receptor with fluvoxamine ameliorates pressure-overload-induced hypertrophy and dysfunctions. | Expert opinion on therapeutic targets 20101001 |
| HTR2A is associated with SSRI response in major depressive disorder in a Japanese cohort. | Neuromolecular medicine 20100901 |
| Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). | The Cochrane database of systematic reviews 20100804 |
| Metabolism of ramelteon in human liver microsomes and correlation with the effect of fluvoxamine on ramelteon pharmacokinetics. | Drug metabolism and disposition: the biological fate of chemicals 20100801 |
| Cabergoline, a dopamine receptor agonist, has an antidepressant-like property and enhances brain-derived neurotrophic factor signaling. | Psychopharmacology 20100801 |
| Selective serotonin-reuptake inhibitors in the treatment of panic disorder: a systematic review of placebo-controlled studies. | Expert review of neurotherapeutics 20100801 |
| Disinhibition as a side effect of treatment with fluvoxamine in pediatric patients with obsessive-compulsive disorder. | Journal of child and adolescent psychopharmacology 20100801 |
| Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression. | International clinical psychopharmacology 20100701 |
| Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update. | Postgraduate medicine 20100701 |
| Therapeutic efficacy assessment of weak variable magnetic fields with low value of induction in patients with drug-resistant depression. | Journal of affective disorders 20100601 |
| Association analysis of SIGMAR1 with major depressive disorder and SSRI response. | Neuropharmacology 20100601 |
| Selective serotonin reuptake inhibitors and the risk of cataracts: a nested case-control study. | Ophthalmology 20100601 |
| Duration of untreated illness and antidepressant fluvoxamine response in major depressive disorder. | Psychiatry and clinical neurosciences 20100601 |
| Role of hydrophobic substituents on the terminal nitrogen of histamine in receptor binding and agonist activity: development of an orally active histamine type 3 receptor agonist and evaluation of its antistress activity in mice. | Journal of medicinal chemistry 20100513 |
| Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts. | Pediatrics 20100501 |
| Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data. | Archives of general psychiatry 20100501 |
| Prevalence of trait anxiety in a sample of depressed inpatients and its influence on response to antidepressants. | Journal of psychopharmacology (Oxford, England) 20100401 |
| Influence of gender and menopausal status on antidepressant treatment response in depressed inpatients. | Journal of psychopharmacology (Oxford, England) 20100401 |
| Interactions at human ether-à-go-go-related gene channels. | Toxicological sciences : an official journal of the Society of Toxicology 20100401 |
| Protein binding-dependent decreases in hERG channel blocker potency assessed by whole-cell voltage clamp in serum. | Journal of cardiovascular pharmacology 20100401 |
| Cognition and depression: the effects of fluvoxamine, a sigma-1 receptor agonist, reconsidered. | Human psychopharmacology 20100401 |
| Clinical features and treatment characteristics of compulsive hoarding in Japanese patients with obsessive-compulsive disorder. | CNS spectrums 20100401 |
| [Prediction of antidepressant response to milnacipran and fluvoxamine using pharmacogenetical methods]. | Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20100401 |
| [Customized pharmacotherapies in schizophrenia]. | Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20100401 |
| [Possibility of a pharmacogenetic approach for prediction and personalized medication in major depressive disorder treatment]. | Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20100401 |
| Involvement of the 5-HT(1A) receptor in the anti-immobility effects of fluvoxamine in the forced swimming test and mouse strain differences in 5-HT(1A) receptor binding. | European journal of pharmacology 20100310 |
| Selective serotonin re-uptake inhibitors decrease the cytokine-induced endothelial adhesion molecule expression, the endothelial adhesiveness to monocytes and the circulating levels of vascular adhesion molecules. | International journal of cardiology 20100304 |
| Predictors of treatment response to fluvoxamine in obsessive-compulsive disorder: an fMRI study. | Journal of psychiatric research 20100301 |
| Translin-associated factor X gene (TSNAX) may be associated with female major depressive disorder in the Japanese population. | Neuromolecular medicine 20100301 |
| The use of antidepressants in clinical practice: focus on agomelatine. | Human psychopharmacology 20100301 |
| Are typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorder. | The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20100301 |
| Fluvoxamine pharmacokinetics in healthy elderly subjects and elderly patients with chronic heart failure. | British journal of clinical pharmacology 20100301 |
| Fluvoxamine and sigma-1 receptor agonists dehydroepiandrosterone (DHEA)-sulfate induces the Ser473-phosphorylation of Akt-1 in PC12 cells. | Life sciences 20100227 |
| Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder. | Journal of affective disorders 20100201 |
| Cytochrome P450 2C19 inhibitory activity of common berry constituents. | Phytotherapy research : PTR 20100201 |
| Brugada syndrome ECG provoked by the selective serotonin reuptake inhibitor fluvoxamine. | Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 20100201 |
| Gestational exposure to the organophosphate chlorpyrifos alters social-emotional behaviour and impairs responsiveness to the serotonin transporter inhibitor fluvoxamine in mice. | Psychopharmacology 20100101 |
| Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population. | Neuropsychobiology 20100101 |
| Effects of cigarette smoking and cytochrome P450 2D6 genotype on fluvoxamine concentration in plasma of Japanese patients. | Biological & pharmaceutical bulletin 20100101 |
| Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat. | PloS one 20100101 |
| Fluvoxamine versus other anti-depressive agents for depression. | The Cochrane database of systematic reviews 20100101 |
| Behavioral despair during a water maze learning task in mice. | Experimental animals 20100101 |
| Inhibitory action of fluvoxamine on Kv1.5 currents. | Biological & pharmaceutical bulletin 20100101 |
| Extended-release fluvoxamine and improvements in quality of life in patients with obsessive-compulsive disorder. | Comprehensive psychiatry 20100101 |
| No effect of adding brief dynamic therapy to pharmacotherapy in the treatment of obsessive-compulsive disorder with concurrent major depression. | Psychotherapy and psychosomatics 20100101 |
| Ecchymoses as an adverse effect of fluvoxamine treatment in an adolescent girl. | General hospital psychiatry 20100101 |
| Aripiprazole as an augmentation agent in treatment-resistant body dysmorphic disorder. | Clinical drug investigation 20100101 |
| [Selective serotonin reuptake inhibitors and mammary pathologies]. | Voprosy onkologii 20100101 |
| Pharmacologically distinctive behaviors other than burying marbles during the marble burying test in mice. | Pharmacology 20100101 |
| Onset of clinical effects and plasma concentration of fluvoxamine in Japanese patients. | Biological & pharmaceutical bulletin 20100101 |
| Influence of antidepressant drugs on chlorpromazine metabolism in human liver--an in vitro study. | Pharmacological reports : PR 20100101 |
| Can the sigma-1 receptor agonist fluvoxamine prevent schizophrenia? | CNS & neurological disorders drug targets 20091201 |
| Photosensitivity associated with selective serotonin reuptake inhibitors. | Clinical and experimental dermatology 20091201 |
| Prevalence of depression in a general hospital in Izhevsk, Russia. | Nordic journal of psychiatry 20091101 |
| Trichotilliomania responding to low-dose fluvoxamine. | Psychiatry and clinical neurosciences 20091001 |
| In vitro and in vivo evaluation of the inhibition potential of risperidone toward clozapine biotransformation. | British journal of clinical pharmacology 20091001 |
| Observation of QTc prolongation in an adolescent girl during fluvoxamine pharmacotherapy. | Journal of child and adolescent psychopharmacology 20091001 |
| Utility of small-animal positron emission tomographic imaging of rats for preclinical development of drugs acting on the serotonin transporter. | The international journal of neuropsychopharmacology 20090901 |
| The effects of serotonin and/or noradrenaline reuptake inhibitors on impulsive-like action assessed by the three-choice serial reaction time task: a simple and valid model of impulsive action using rats. | Behavioural pharmacology 20090901 |
| Sigma-1 receptors and selective serotonin reuptake inhibitors: clinical implications of their relationship. | Central nervous system agents in medicinal chemistry 20090901 |
| Last observation carried forward: a crystal ball? | Journal of biopharmaceutical statistics 20090901 |
| Behavioral effects of four antidepressants on an ischemic rat model of emotional disturbances. | Behavioural brain research 20090812 |
| Association analysis of group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a Japanese population. | Progress in neuro-psychopharmacology & biological psychiatry 20090801 |
| ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine. | Journal of clinical psychopharmacology 20090801 |
| Musical obsession: repeated auditory imagery of a cell phone ring tone. | Psychiatry and clinical neurosciences 20090801 |
| Effects of Psilocybe argentipes on marble-burying behavior in mice. | Bioscience, biotechnology, and biochemistry 20090801 |
| Efficacy, tolerability and side-effect profile of fluvoxamine for major depression: meta-analysis. | Journal of psychopharmacology (Oxford, England) 20090701 |
| Effect of smoking and CYP2D6 polymorphisms on the extent of fluvoxamine-alprazolam interaction in patients with psychosomatic disease. | European journal of clinical pharmacology 20090701 |
| Effects of antidepressants on GluR2 Q/R site-RNA editing in modified HeLa cell line. | Neuroscience research 20090701 |
| A transition model for ordinal response data with random dropout: an application to the fluvoxamine data. | Journal of biopharmaceutical statistics 20090701 |
| Changes of functional MRI findings in a patient whose pathological gambling improved with fluvoxamine. | Yonsei medical journal 20090630 |
| A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder. | The Journal of clinical psychiatry 20090601 |
| [Pharmaceutical treatment of binge eating disorder]. | Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20090601 |
| 5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients. | Psychiatry research 20090515 |
| Spectrofluorimetric determination of fluvoxamine in dosage forms and plasma via derivatization with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole. | Journal of fluorescence 20090501 |
| Fluvoxamine exerts anorexic effect in 5-HT2C receptor mutant mice with heterozygous mutation of beta-endorphin gene. | The international journal of neuropsychopharmacology 20090501 |
| Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2c receptor and acyl ghrelin. | Biological psychiatry 20090501 |
| Spectrophotometric study for the reaction between fluvoxamine and 1,2-naphthoquinone-4-sulphonate: Kinetic, mechanism and use for determination of fluvoxamine in its dosage forms. | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20090501 |
| Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. | The American journal of psychiatry 20090501 |
| Inhibitory effect of selective serotonin reuptake inhibitors on the vesicular monoamine transporter 2. | Neuroscience letters 20090501 |
| Pharmacokinetics and efficacy of fluvoxamine and amitriptyline in depression. | Journal of pharmacological sciences 20090501 |
| Pharmacological REM sleep suppression paradoxically improves rather than impairs skill memory. | Nature neuroscience 20090401 |
| Musical obsession or pseudohallucination: electrophysiological standpoint. | Psychiatry and clinical neurosciences 20090401 |
| Activation adverse events induced by the selective serotonin reuptake inhibitor fluvoxamine in children and adolescents. | Journal of child and adolescent psychopharmacology 20090401 |
| Invivo antioxidant status: a putative target of antidepressant action. | Progress in neuro-psychopharmacology & biological psychiatry 20090317 |
| Delirium due to a drug-drug interaction of lithium and an NSAID. | The journal of nutrition, health & aging 20090301 |
| Impact of ovarian hormones on the modulation of the serotonin transporter by fluvoxamine. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20090201 |
| A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder. | The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101 |
| Interaction between SERTPR and stressful life events on response to antidepressant treatment. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20090101 |
| Intracerebroventricular fluvoxamine administration inhibited pain behavior but increased Fos expression in affective pain pathways. | Pharmacology, biochemistry, and behavior 20090101 |
| Effects of intrathecal administration of newer antidepressants on mechanical allodynia in rat models of neuropathic pain. | Neuroscience research 20090101 |
| Hyperpigmentation with amisulpride. | The Australian and New Zealand journal of psychiatry 20090101 |
| Severe eating disorder in a 28-year-old man with William's syndrome. | The American journal of psychiatry 20090101 |
| Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labelled, two-arm proof-of-concept study. | Acta dermato-venereologica 20090101 |
| Tiagabine augmentation to fluvoxamine-risperidone combination in the treatment of obsessive-compulsive disorder. | The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20090101 |
| CLOCK may predict the response to fluvoxamine treatment in Japanese major depressive disorder patients. | Neuromolecular medicine 20090101 |
| Antidepressants inhibit P2X4 receptor function: a possible involvement in neuropathic pain relief. | Molecular pain 20090101 |
| Antiulcer activity of fluvoxamine in rats and its effect on oxidant and antioxidant parameters in stomach tissue. | BMC gastroenterology 20090101 |
| Fluvoxamine in the treatment of corticosteroid-induced obsessive-compulsive disorder. | Clinical neuropharmacology 20090101 |
| Orphan nuclear receptor Rev-erb alpha gene (NR1D1) and fluvoxamine response in major depressive disorder in the Japanese population. | Neuropsychobiology 20090101 |
| Effective treatment with low-dose fluvoxamine for obsessive-compulsive disorder after neurosurgery: a case report. | Clinical neuropharmacology 20090101 |
| [SSRI antidepressants and negative schizophrenic symptoms: differences between paroxetine and fluvoxamine in patients treated with olanzapine]. | Rivista di psichiatria 20090101 |
| Automated analysis of fluvoxamine in rat plasma using a column-switching system and ion-pair high-performance liquid chromatography. | Biomedical chromatography : BMC 20081201 |
| Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neurons. | Neuropharmacology 20081201 |
| Kinetic and thermodynamic assessment of binding of serotonin transporter inhibitors. | The Journal of pharmacology and experimental therapeutics 20081201 |
| Interindividual variation in relative CYP1A2/3A4 phenotype influences susceptibility of clozapine oxidation to cytochrome P450-specific inhibition in human hepatic microsomes. | Drug metabolism and disposition: the biological fate of chemicals 20081201 |
| Dose-dependent effect of the CYP2D6 genotype on the steady-state fluvoxamine concentration. | Therapeutic drug monitoring 20081201 |
| Reinforcement magnitude modulation of rate-dependent effects of fluvoxamine and desipramine in the rat. | Behavioural pharmacology 20081201 |
| Fluvoxamine inhibits weight gain and food intake in food restricted hyperphagic Wistar rats. | Biological & pharmaceutical bulletin 20081201 |
| Controlled-release fluvoxamine in obsessive-compulsive disorder and social phobia. | Drugs of today (Barcelona, Spain : 1998) 20081201 |
| Influence of quinidine, fluvoxamine, and ketoconazole on the enantioselective pharmacokinetics of citalopram in rats. | Canadian journal of physiology and pharmacology 20081101 |
| Pharmacokinetic interaction between tandospirone and fluvoxamine in the rat contextual conditioned fear stress model and its functional consequence: Involvement of cytochrome P450 3A4. | Psychiatry and clinical neurosciences 20081001 |
| Mouse strain differences in immobility and sensitivity to fluvoxamine and desipramine in the forced swimming test: analysis of serotonin and noradrenaline transporter binding. | European journal of pharmacology 20080911 |
| Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots. | Journal of pharmaceutical and biomedical analysis 20080910 |
| Anxiety-like behaviors produced by acute fluoxetine administration in male Fischer 344 rats are prevented by prior exercise. | Psychopharmacology 20080801 |
| Some selective serotonin reuptake inhibitors inhibit dynamin I guanosine triphosphatase (GTPase). | Biological & pharmaceutical bulletin 20080801 |
| Potentiation of morphine-induced conditioned place preference with concurrent use of amantadine and fluvoxamine by the intraperitoneal and intracerebroventricular injection in rat. | Behavioural brain research 20080719 |
| The effect of fluvoxamine on the pharmacokinetics, safety, and tolerability of ramosetron in healthy subjects. | European journal of clinical pharmacology 20080701 |
| Pharmacokinetic-pharmacodynamic modelling of fluvoxamine 5-HT transporter occupancy in rat frontal cortex. | British journal of pharmacology 20080701 |
| Asperger's syndrome: from hiding to thriving. | The Nurse practitioner 20080701 |
| Extended-release fluvoxamine (Luvox CR). | The Medical letter on drugs and therapeutics 20080630 |
| Additive effects of combined application of multiple hERG blockers. | Journal of cardiovascular pharmacology 20080601 |
| Concentration-response relationship for fluvoxamine using remission as an endpoint: a receiver operating characteristics curve analysis in major depression. | Journal of clinical psychopharmacology 20080601 |
| Predictors of antidepressant response to fluvoxamine obtained using the three-factor structures of the Montgomery and Asberg Depression Rating Scale for major depressive disorders in Japanese patients. | Psychiatry and clinical neurosciences 20080601 |
| Fluvoxamine as a sigma-1 receptor agonist improved cognitive impairments in a patient with schizophrenia. | Progress in neuro-psychopharmacology & biological psychiatry 20080515 |
| Antidepressant response and intolerance to SSRI is not influenced by G-protein beta3 subunit gene C825T polymorphism in Japanese major depressive patients. | Progress in neuro-psychopharmacology & biological psychiatry 20080515 |
| Estimation of the area under the concentration-time curve of racemic lansoprazole by using limited plasma concentration of lansoprazole enantiomers. | European journal of clinical pharmacology 20080501 |
| The role of RNA editing of the serotonin 2C receptor in a rat model of oro-facial neuropathic pain. | The European journal of neuroscience 20080501 |
| Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis. | Obstetrics and gynecology 20080501 |
| Pharmacokinetic modeling of non-linear brain distribution of fluvoxamine in the rat. | Pharmaceutical research 20080401 |
| Patient satisfaction with antidepressants: an Internet-based study. | Journal of affective disorders 20080401 |
| Vascular reactivity, 5-HT uptake, and blood pressure in the serotonin transporter knockout rat. | American journal of physiology. Heart and circulatory physiology 20080401 |
| Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy. | Journal of clinical pharmacy and therapeutics 20080401 |
| Quality assessment of fluoxetine and fluvoxamine pharmaceutical formulations purchased in different countries or via the Internet by 19F and 2D DOSY 1H NMR. | Journal of pharmaceutical and biomedical analysis 20080313 |
| Mechanistic model for the acute effect of fluvoxamine on 5-HT and 5-HIAA concentrations in rat frontal cortex. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20080303 |
| Opposite effects of SSRIs and tandospirone in the treatment of REM sleep behavior disorder. | Sleep medicine 20080301 |
| Influence of negative cognition on the parental bonding instrument (PBI) in patients with major depression. | The Journal of nervous and mental disease 20080301 |
| Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs. | Biological psychiatry 20080215 |
| Geometric mean IELT and premature ejaculation: appropriate statistics to avoid overestimation of treatment efficacy. | The journal of sexual medicine 20080201 |
| Reinforcement magnitude modulates the rate-dependent effects of fluvoxamine and desipramine on fixed-interval responding in the pigeon. | Behavioural pharmacology 20080201 |
| A clinically relevant review of tizanidine hydrochloride dose relationships to pharmacokinetics, drug safety and effectiveness in healthy subjects and patients. | International journal of clinical practice 20080201 |
| Shortened protocol in practical [11C]SA4503-PET studies for sigma1 receptor quantification. | Annals of nuclear medicine 20080201 |
| Selective serotonin reuptake inhibitors fluvoxamine and paroxetine restore forced exercise-induced temperature dysregulation in ovariectomized mice. | European journal of pharmacology 20080128 |
| Antidepressant drugs for narcolepsy. | The Cochrane database of systematic reviews 20080123 |
| An unambiguous assay for the cloned human sigma1 receptor reveals high affinity interactions with dopamine D4 receptor selective compounds and a distinct structure-affinity relationship for butyrophenones. | European journal of pharmacology 20080114 |
| Molecular modeling of two CYP2C19 SNPs and its implications for personalized drug design. | Protein and peptide letters 20080101 |
| In vitro and in vivo evaluations of cytochrome P450 1A2 interactions with duloxetine. | Clinical pharmacokinetics 20080101 |
| [Psychopharmacological treatment and quality of life in obsessive compulsive disorder]. | Turk psikiyatri dergisi = Turkish journal of psychiatry 20080101 |
| [Fluvoxamine, amitriptyline and transcranial electrostimulation of the brain in the treatment of chronic daily headache]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20080101 |
| Psychological interventions for major depression in primary care: a meta-analytic review of randomized controlled trials. | General hospital psychiatry 20080101 |
| Potentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathways. | PloS one 20080101 |
| Enzyme inhibition and induction in liver disease. | Current clinical pharmacology 20080101 |
| Outcome of additional behaviour therapy including treatment discontinuation for fluvoxamine non-responders with obsessive-compulsive disorder. | Psychotherapy and psychosomatics 20080101 |
| Reversible tremor and myoclonus associated with topiramate-fluvoxamine coadministration. | Clinical neuropharmacology 20080101 |
| [Additional treatment in chronic pain syndrome due to hip and knee arthritis with the selective serotonin reuptake inhibitor fluvoxamine (Fevarin]. | Zeitschrift fur Orthopadie und Unfallchirurgie 20080101 |
| 12-month follow-up study of drug treatment in pathological gamblers: a primary outcome study. | Journal of clinical psychopharmacology 20071201 |
| Effects of the serotonin and noradrenaline reuptake inhibitor (SNRI) milnacipran on marble burying behavior in mice. | Biological & pharmaceutical bulletin 20071201 |
| Successful treatment of Meige's syndrome induced by risperidone and fluvoxamine with olanzapine monotherapy in schizophrenia. | Psychiatry and clinical neurosciences 20071201 |
| Use of isolated hepatocyte preparations for cytochrome P450 inhibition studies: comparison with microsomes for Ki determination. | Drug metabolism and disposition: the biological fate of chemicals 20071101 |
| Pharmacokinetic-pharmacodynamic modeling of the effect of fluvoxamine on p-chloroamphetamine-induced behavior. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20071101 |
| Use of medication in children with psychiatric disorders. | Community practitioner : the journal of the Community Practitioners' & Health Visitors' Association 20071101 |
| [Compulsive buying: psychological and biological treatment]. | L'Encephale 20071101 |
| High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a positron emission tomography study using [11C]SA4503. | Biological psychiatry 20071015 |
| Fluvoxamine, a selective serotonin reuptake inhibitor, and 5-HT2C receptor inactivation induce appetite-suppressing effects in mice via 5-HT1B receptors. | The international journal of neuropsychopharmacology 20071001 |
| Gene expression changes in peripheral mononuclear cells from schizophrenic patients treated with a combination of antipsychotic with fluvoxamine. | Progress in neuro-psychopharmacology & biological psychiatry 20071001 |
| Rapid and sensitive bioanalytical method for measurement of fluvoxamine in human serum using 4-chloro-7-nitrobenzofurazan as pre-column derivatization agent: application to a human pharmacokinetic study. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20071001 |
| Quetiapine and drug interactions: evidence from a routine therapeutic drug monitoring service. | The Journal of clinical psychiatry 20071001 |
| Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study. | The Journal of clinical psychiatry 20071001 |
| [Clozapine-resistant schizophrenia related to an increased metabolism and benefit of fluvoxamine: four case reports]. | L'Encephale 20071001 |
| Predictors of course in obsessive-compulsive disorder: logistic regression versus Cox regression for recurrent events. | Acta psychiatrica Scandinavica 20070901 |
| Stalking and Huntington's disease: a neurobiological link? | Journal of forensic sciences 20070901 |
| [Review of pharmacological efficacies and side effects of antidepressants]. | Nihon rinsho. Japanese journal of clinical medicine 20070901 |
| Clinical prediction of antidepressant response in mood disorders: linear multivariate vs. neural network models. | Psychiatry research 20070830 |
| Violent dreaming and antidepressant drugs: or how paroxetine made me dream that I was fighting Saddam Hussein. | Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 20070815 |
| The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine. | Journal of psychopharmacology (Oxford, England) 20070801 |
| Saturable uptake of lipophilic amine drugs into isolated hepatocytes: mechanisms and consequences for quantitative clearance prediction. | Drug metabolism and disposition: the biological fate of chemicals 20070801 |
| Gender differences in the clinical effects of fluvoxamine and milnacipran in Japanese major depressive patients. | Psychiatry and clinical neurosciences 20070801 |
| Therapeutic drug monitoring of plasma fluvoxamine levels for treating bulimia nervosa. | Psychiatry and clinical neurosciences 20070801 |
| Antidepressant response in the elderly. | Psychiatry research 20070730 |
| Enhanced long-term synaptic depression in an animal model of depression. | Biological psychiatry 20070701 |
| Timolol metabolism in human liver microsomes is mediated principally by CYP2D6. | Drug metabolism and disposition: the biological fate of chemicals 20070701 |
| Role of 5-HT receptor antagonists in mediating intracavernous pressure response induced by fluvoxamine in conscious rats. | The journal of sexual medicine 20070701 |
| Lithium addition in antidepressant-resistant depression: effects on platelet 5-HT, plasma 5-HT and plasma 5-HIAA concentration. | Progress in neuro-psychopharmacology & biological psychiatry 20070630 |
| Piloerection induced by replacing fluvoxamine with milnacipran. | British journal of clinical pharmacology 20070601 |
| Involvement of the sigma1 receptor in inhibiting activity of fluvoxamine on marble-burying behavior: comparison with paroxetine. | European journal of pharmacology 20070601 |
| Psychotic disorder in a patient with central and extrapontine myelinolysis. | Psychiatry and clinical neurosciences 20070601 |
| Serotonin-selective reuptake inhibitor-induced enuresis in three pediatric cases. | Journal of child and adolescent psychopharmacology 20070601 |
| Toxicity and hazard of selective serotonin reuptake inhibitor antidepressants fluoxetine, fluvoxamine, and sertraline to algae. | Ecotoxicology and environmental safety 20070501 |
| Serotonin transporter function, but not expression, is dependent on brain-derived neurotrophic factor (BDNF): in vivo studies in BDNF-deficient mice. | Journal of neurochemistry 20070501 |
| Effects of milnacipran and fluvoxamine on hyperemotional behaviors and the loss of tryptophan hydroxylase-positive cells in olfactory bulbectomized rats. | Psychopharmacology 20070501 |
| The selective serotonin reuptake inhibitor fluvoxamine suppresses post-feeding hyperactivity induced by food restriction in rats. | Pharmacology, biochemistry, and behavior 20070501 |
| EPMS under antidepressive therapy with fluvoxamine and concomitant antibiotic therapy with clindamycin. | Pharmacopsychiatry 20070501 |
| 3D structure modeling of cytochrome P450 2C19 and its implication for personalized drug design. | Biochemical and biophysical research communications 20070406 |
| Fluvoxamine treatment of generalized social anxiety disorder in Japan: a randomized double-blind, placebo-controlled study. | The international journal of neuropsychopharmacology 20070401 |
| Time-dependent clearance decrements of fluvoxamine in depressed inpatients: a clinical evaluation. | Journal of clinical psychopharmacology 20070401 |
| Dose-dependent effects of the 3435 C>T genotype of ABCB1 gene on the steady-state plasma concentration of fluvoxamine in psychiatric patients. | Therapeutic drug monitoring 20070401 |
| Remarkable antidepressant augmentation effect of raloxifene, a selective estrogen receptor modulator, in a partial responder to fluvoxamine: a case report. | The Journal of clinical psychiatry 20070401 |
| HPLC method for the determination of fluvoxamine in human plasma and urine for application to pharmacokinetic studies. | Journal of pharmaceutical and biomedical analysis 20070312 |
| Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070301 |
| A neural network model for combining clinical predictors of antidepressant response in mood disorders. | Journal of affective disorders 20070301 |
| Stimulation of catecholamine synthesis via activation of p44/42 MAPK in cultured bovine adrenal medullary cells by milnacipran. | Naunyn-Schmiedeberg's archives of pharmacology 20070301 |
| Benefits of cognitive-behavioural therapy for children and youth with obsessive-compulsive disorder: re-examination of the evidence. | The Australian and New Zealand journal of psychiatry 20070301 |
| Latent-variable models for longitudinal data with bivariate ordinal outcomes. | Statistics in medicine 20070227 |
| Role of atypical opiates in OCD. Experimental approach through the study of 5-HT(2A/C) receptor-mediated behavior. | Psychopharmacology 20070201 |
| Fluvoxamine in the treatment of late-life depression: how much we know coming from randomized controlled trials: comment on article by Dr Rossini and colleagues. | Journal of clinical psychopharmacology 20070201 |
| Sleep-related problems among children and adolescents with anxiety disorders. | Journal of the American Academy of Child and Adolescent Psychiatry 20070201 |
| Effectiveness of a meditation-based stress management program as an adjunct to pharmacotherapy in patients with anxiety disorder. | Journal of psychosomatic research 20070201 |
| Identification of human cytochrome P450 enzymes involved in the major metabolic pathway of fluvoxamine. | Xenobiotica; the fate of foreign compounds in biological systems 20070201 |
| Re-evaluation of tacrine hepatotoxicity using gel entrapped hepatocytes. | Toxicology letters 20070130 |
| Proton magnetic resonance spectroscopy reveals an abnormality in the anterior cingulate of a subgroup of obsessive-compulsive disorder patients. | Psychiatry research 20070115 |
| Fluvoxamine treatment and D2 receptors: a pet study on OCD drug-naïve patients. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20070101 |
| Chronic fluoxetine increases cytosolic phospholipase A(2) activity and arachidonic acid turnover in brain phospholipids of the unanesthetized rat. | Psychopharmacology 20070101 |
| Population pharmacokinetic model of fluvoxamine in rats: utility for application in animal behavioral studies. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20070101 |
| Spectrofluorometric determination of fluvoxamine in dosage forms, spiked plasma, and real human plasma by derivatization with fluorescamine. | Journal of AOAC International 20070101 |
| [Methylphenidate augmentation of fluvoxamine for treatment-resistant depression: a case report and review literature]. | Turk psikiyatri dergisi = Turkish journal of psychiatry 20070101 |
| Dopamine and serotonin metabolism in response to chronic administration of fluvoxamine and haloperidol combined treatment. | Journal of neural transmission (Vienna, Austria : 1996) 20070101 |
| Effect of fluvoxamine on the pharmacokinetics of roflumilast and roflumilast N-oxide. | Clinical pharmacokinetics 20070101 |
| Motivation to change as a predictor of treatment response in obsessive compulsive disorder. | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20070101 |
| Status epilepticus following intentional overdose of fluvoxamine: a case report with serum fluvoxamine concentration. | Clinical toxicology (Philadelphia, Pa.) 20070101 |
| Effects of fluvoxamine on anxiety, depression, and subjective handicaps of chronic dizziness patients with or without neuro-otologic diseases. | Journal of vestibular research : equilibrium & orientation 20070101 |
| Compulsive buying and binge eating disorder--a case vignettes. | Progress in neuro-psychopharmacology & biological psychiatry 20061230 |
| Possible involvement of opioidergic systems in the antinociceptive effect of the selective serotonin reuptake inhibitors in sciatic nerve-injured mice. | European journal of pharmacology 20061215 |
| Decision-making functioning as a predictor of treatment outcome in anorexia nervosa. | Psychiatry research 20061207 |
| The effects of human CYP2C8 genotype and fluvoxamine on the pharmacokinetics of rosiglitazone in healthy subjects. | British journal of clinical pharmacology 20061201 |
| Visual hallucinations and amnesia associated with zolpidem triggered by fluvoxamine: a possible interaction. | International psychogeriatrics 20061201 |
| Lack of enhanced effect of antipsychotics combined with fluvoxamine on acetylcholine release in rat prefrontal cortex. | Journal of pharmacological sciences 20061201 |
| A preliminary study on the interaction of fluvoxamine and adenosine receptor on isolated Guinea-pig atria. | The International journal of neuroscience 20061201 |
| Effects of fluvoxamine on behavioral and psychological symptoms of dementia in Alzheimer's disease: a report of three cases. | Fukushima journal of medical science 20061201 |
| Trichotillomania: a treatment overview. | The Journal of practical nursing 20061201 |
| Antidepressants enhance the antinociceptive effects of carbamazepine in the acetic acid-induced writhing test in mice. | European journal of pharmacology 20061121 |
| Simultaneous determination of fluvoxamine isomers and quetiapine in human plasma by means of high-performance liquid chromatography. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20061107 |
| Phenytoin as an augmentation for SSRI failures: a small controlled study. | Journal of affective disorders 20061101 |
| Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors. | Behavioural pharmacology 20061101 |
| Role of serotonin type 1A receptors in fluvoxamine-induced inhibition of marble-burying behavior in mice. | Behavioural pharmacology 20061101 |
| Fluvoxamine effects on concurrent ethanol- and food-maintained behaviors. | Experimental and clinical psychopharmacology 20061101 |
| [Role of the serotonergic nervous system in anxiety disorders and the anxiolytic mechanism of selective serotonin reuptake inhibitors]. | Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20061101 |
| Effects of repetitive transcranial magnetic stimulation on [11C]raclopride binding and cognitive function in patients with depression. | Journal of affective disorders 20061001 |
| Identification of the time-point which gives a plasma rabeprazole concentration that adequately reflects the area under the concentration-time curve. | European journal of clinical pharmacology 20061001 |
| Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression. | Journal of clinical psychopharmacology 20061001 |
| Somatic symptoms in children and adolescents with anxiety disorders. | Journal of the American Academy of Child and Adolescent Psychiatry 20061001 |
| [Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents]. | Presse medicale (Paris, France : 1983) 20061001 |
| [Is the suicidal risk assessment scale RSD of predictive value?]. | L'Encephale 20061001 |
| Hippocampal synapsin I, growth-associated protein-43, and microtubule-associated protein-2 immunoreactivity in learned helplessness rats and antidepressant-treated rats. | Neuroscience 20060901 |
| Fluvoxamine, a selective serotonin reuptake inhibitor, exerts its antiallodynic effects on neuropathic pain in mice via 5-HT2A/2C receptors. | Neuropharmacology 20060901 |
| Effects of chronic fluvoxamine on ethanol- and food-maintained behaviors. | Life sciences 20060822 |
| From selective to highly selective SSRIs: a comparison of the antinociceptive properties of fluoxetine, fluvoxamine, citalopram and escitalopram. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20060801 |
| Serotonin transporter gene-linked polymorphic region: possible pharmacogenetic implications of rare variants. | Psychiatric genetics 20060801 |
| Poor correlation between 6beta-hydroxycortisol:cortisol molar ratios and midazolam clearance as measure of hepatic CYP3A activity. | British journal of clinical pharmacology 20060801 |
| Fluvoxamine-induced bullous eruption mimicking hand-foot syndrome and intertrigo-like eruption: rare cutaneous presentations and elusive pathogenesis. | Journal of the American Academy of Dermatology 20060801 |
| Effect of fluvoxamine and erythromycin on the pharmacokinetics of oral lidocaine. | Basic & clinical pharmacology & toxicology 20060801 |
| [Drug interaction of fluvoxamine, a selective serotonin reuptake inhibitor]. | Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20060801 |
| Ethanol inhibits clearance of brain serotonin by a serotonin transporter-independent mechanism. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20060614 |
| The effect of chronic co-administration of fluvoxamine and haloperidol compared to clozapine on the GABA system in the rat frontal cortex. | The international journal of neuropsychopharmacology 20060601 |
| Hypersalivation induced by olanzapine with fluvoxamine. | Progress in neuro-psychopharmacology & biological psychiatry 20060601 |
| Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders. | The Psychiatric clinics of North America 20060601 |
| Successful treatment for obsessive-compulsive disorder with addition of low-dose risperidone to fluvoxamine: implications for plasma levels of catecholamine metabolites and serum brain-derived neurotrophic factor levels. | Psychiatry and clinical neurosciences 20060601 |
| Effects of caffeine on the kinetics of fluvoxamine and its major metabolite in plasma after a single oral dose of the drug. | Therapeutic drug monitoring 20060601 |
| Identification of a single time-point for plasma lansoprazole measurement that adequately reflects area under the concentration-time curve. | Therapeutic drug monitoring 20060601 |
| Serotonin syndrome caused by minimum doses of SSRIS in a patient with spinal cord injury. | Fukushima journal of medical science 20060601 |
| Selective serotonin reuptake inhibitors in sewage influents and effluents from Tromsø, Norway. | Journal of chromatography. A 20060519 |
| Chronic antidepressants potentiate via sigma-1 receptors the brain-derived neurotrophic factor-induced signaling for glutamate release. | The Journal of biological chemistry 20060505 |
| Relapse during a 6-month continuation treatment with fluvoxamine in an Italian population: the role of clinical, psychosocial and genetic variables. | Progress in neuro-psychopharmacology & biological psychiatry 20060501 |
| The spermicidal and antitrichomonas activities of SSRI antidepressants. | Bioorganic & medicinal chemistry letters 20060501 |
| Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine. | Clinical pharmacology and therapeutics 20060501 |
| Quetiapine-fluvoxamine combination during pregnancy and while breastfeeding. | Archives of women's mental health 20060501 |
| Dramatic remission of treatment-resistant depression after the cessation of tricyclic antidepressants. | Pharmacopsychiatry 20060501 |
| Polymorphisms in the 5-hydroxytryptamine 2A receptor and CytochromeP4502D6 genes synergistically predict fluvoxamine-induced side effects in japanese depressed patients. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20060401 |
| T3 augmentation of SSRI resistant depression. | Journal of affective disorders 20060401 |
| Tolerability and safety of fluvoxamine and other antidepressants. | International journal of clinical practice 20060401 |
| Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trial. | Journal of clinical psychopharmacology 20060401 |
| Time course of in vivo 5-HTT transporter occupancy by fluvoxamine. | Journal of clinical psychopharmacology 20060401 |
| Different effects of fluvoxamine on rabeprazole pharmacokinetics in relation to CYP2C19 genotype status. | British journal of clinical pharmacology 20060301 |
| Effects of co-administration of a selective serotonin reuptake inhibitor and monoamine oxidase inhibitors on 5-HT-related behavior in rats. | European journal of pharmacology 20060227 |
| Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin. | Journal of affective disorders 20060201 |
| Dopamine release in human neocortical slices: characterization of inhibitory autoreceptors and of nicotinic acetylcholine receptor-evoked release. | Brain research bulletin 20060130 |
| Desensitization of 5-HT2A receptor function by chronic administration of selective serotonin reuptake inhibitors. | Brain research 20060105 |
| Time course of dopamine D2 receptor occupancy by clozapine with medium and high plasma concentrations. | Progress in neuro-psychopharmacology & biological psychiatry 20060101 |
| Effects of chronic treatment with fluvoxamine and paroxetine during adolescence on serotonin-related behavior in adult male rats. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20060101 |
| Serotonin syndrome induced by fluvoxamine and oxycodone. | The Annals of pharmacotherapy 20060101 |
| N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder. | Psychopharmacology 20060101 |
| Cognitive behavioral therapy versus psychosurgery for refractory obsessive-compulsive disorder. | The Journal of neuropsychiatry and clinical neurosciences 20060101 |
| Blindness of clinical evaluators, parents, and children in a placebo-controlled trial of fluvoxamine. | Journal of child and adolescent psychopharmacology 20060101 |
| [Effects of behavior therapy applied to obsessive-compulsive disorders--comparison with drug therapy]. | Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20060101 |
| Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients. | Neuropsychobiology 20060101 |
| Co-administration of ramelton and fluvoxamine to increase levels of interleukin-2. | Medical hypotheses 20060101 |
| [Molecular pharmacogenetic study on antipsychotic-drug therapy responders with depression or schizophrenia]. | Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20060101 |
| [Comparison of the effectiveness of two treatment strategies in inpatients with a depressive disorder. A double-blind study of imipramine followed by lithium addition versus fluvoxamine followed by lithium addition]. | Tijdschrift voor psychiatrie 20060101 |
| [A double-blind controlled study of the efficacy and acceptability of tianeptine in comparison with fluvoxamine in the treatment of depressed alcoholic patients]. | Psychiatria polska 20060101 |
| [Stereotyped behaviors and compulsive complaints of pain improved by fluvoxamine in two cases of frontotemporal dementia]. | Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20060101 |
| Association study between vesicle-associated membrane protein 2 gene polymorphisms and fluvoxamine response in Japanese major depressive patients. | Neuropsychobiology 20060101 |
| Prenatal bupropion exposure enhances the cocaine reward and stress susceptibility in adult mice. | The Chinese journal of physiology 20051231 |
| An appraisal of methods for the analysis of longitudinal categorical data with MAR drop-outs. | Statistics in medicine 20051215 |
| Determination of fluvoxamine in rat plasma by HPLC with pre-column derivatization and fluorescence detection using 4-fluoro-7-nitro-2,1,3-benzoxadiazole. | Biomedical chromatography : BMC 20051201 |
| No modulatory effect of neurokinin-1 receptor antagonists on serotonin uptake in human and rat brain synaptosomes. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20051201 |
| Effect of fluvoxamine on plasma risperidone concentrations in patients with schizophrenia. | Pharmacological research 20051201 |
| An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approaches. | Journal of clinical psychopharmacology 20051201 |
| Fluvoxamine affects sildenafil kinetics and dynamics. | Journal of clinical psychopharmacology 20051201 |
| Comments on article by Albers et al: 'Low-dose fluvoxamine as an adjunct to reduce olanzapine therapeutic dose requirements: a prospective dose-adjusted drug interaction strategy'. | Journal of clinical psychopharmacology 20051201 |
| Pilot study: fluvoxamine treatment for depression and anxiety disorders in children and adolescents with cancer. | Journal of the American Academy of Child and Adolescent Psychiatry 20051201 |
| Fluvoxamine: a selective serotonin re-uptake inhibitor for the treatment of obsessive-compulsive disorder. | Expert opinion on pharmacotherapy 20051201 |
| Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview. | International journal of clinical practice 20051201 |
| Effect of paroxetine on marble-burying behavior in mice. | Methods and findings in experimental and clinical pharmacology 20051201 |
| Acute effects of clozapine-fluvoxamine combination. | Schizophrenia research 20051115 |
| Chronopharmacological study of antidepressants in forced swimming test of mice. | The Journal of pharmacology and experimental therapeutics 20051101 |
| Fluvoxamine and desipramine on fixed-ratio responding: effects of reinforcement magnitude. | Behavioural pharmacology 20051101 |
| Fluvoxamine impairs single-dose caffeine clearance without altering caffeine pharmacodynamics. | British journal of clinical pharmacology 20051101 |
| Approach to novel functional foods for stress control 4. Regulation of serotonin transporter by food factors. | The journal of medical investigation : JMI 20051101 |
| Cognitive therapy and exposure in vivo alone and in combination with fluvoxamine in obsessive-compulsive disorder: a 5-year follow-up. | The Journal of clinical psychiatry 20051101 |
| Altered depression-related behavior and neurochemical changes in serotonergic neurons in mutant R406W human tau transgenic mice. | Brain research 20051012 |
| Effects of dopaminergic and serotonergic manipulation on emotional processing: a pharmacological fMRI study. | NeuroImage 20051001 |
| Sertraline versus fluvoxamine in the treatment of elderly patients with major depression: a double-blind, randomized trial. | Journal of clinical psychopharmacology 20051001 |
| Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity. | Current drug metabolism 20051001 |
| Possible antipsychotic effect of fluvoxamine. | CNS spectrums 20051001 |
| Antidepressant-like effect of coadministration of sulpiride and fluvoxamine in mice. | European journal of pharmacology 20050927 |
| (+)-Norfenfluramine-induced arterial contraction is not dependent on endogenous 5-hydroxytryptamine or 5-hydroxytryptamine transporter. | The Journal of pharmacology and experimental therapeutics 20050901 |
| Imipramine dose in relation to therapeutic plasma level: are clinical trials using imipramine as a positive control flawed? | Psychopharmacology 20050901 |
| Systematic review of randomized controlled trials of atypical antipsychotics and selective serotonin reuptake inhibitors for behavioural problems associated with pervasive developmental disorders. | Journal of psychopharmacology (Oxford, England) 20050901 |
| Insomnia improvement during antidepressant treatment and CLOCK gene polymorphism. | American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 20050805 |
| Serotonin and its antidepressant-sensitive transport in mouse cumulus-oocyte complexes and early embryos. | Biology of reproduction 20050801 |
| The effect of fluvoxamine on ouabain-induced arrhythmia in isolated guinea-pig atria. | Pharmacological research 20050801 |
| Electroanalytical study of fluvoxamine. | Analytical and bioanalytical chemistry 20050801 |
| Exposure assessment and microcosm fate of selected selective serotonin reuptake inhibitors. | Regulatory toxicology and pharmacology : RTP 20050801 |
| Effects of a 5-HT7 receptor antagonist DR4004 on the exploratory behavior in a novel environment and on brain monoamine dynamics in mice. | European journal of pharmacology 20050725 |
| Antidepressant drugs for narcolepsy. | The Cochrane database of systematic reviews 20050720 |
| Effects of fluvoxamine on a multiple schedule of ethanol- and food-maintained behavior in two rat strains. | Psychopharmacology 20050701 |
| Enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes in the presence of fluvoxamine. | British journal of clinical pharmacology 20050701 |
| Rapid screening of selective serotonin re-uptake inhibitors in urine samples using solid-phase microextraction gas chromatography-mass spectrometry. | Analytical and bioanalytical chemistry 20050701 |
| Interaction study between enoxacin and fluvoxamine. | Therapeutic drug monitoring 20050601 |
| Toxicity with selective serotonin reuptake inhibitors. | The American journal of psychiatry 20050601 |
| Prediction of genotoxicity of chemical compounds by statistical learning methods. | Chemical research in toxicology 20050601 |
| Clinical efficacy of fluvoxamine and functional polymorphism in a serotonin transporter gene on childhood autism. | Journal of autism and developmental disorders 20050601 |
| Oniomania--successful treatment with fluvoxamine and cognitive-behavioral psychotherapy. | Psychiatria Danubina 20050601 |
| Effects of chronic selective serotonin reuptake inhibitors on 8-OH-DPAT-induced facilitation of ejaculation in rats: comparison of fluvoxamine and paroxetine. | Psychopharmacology 20050501 |
| Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism. | International clinical psychopharmacology 20050501 |
| Chronic administration of the SSRI fluvoxamine markedly and selectively reduces the sensitivity of cortical serotonergic neurons to footshock stress. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20050501 |
| Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders. | Journal of the American Academy of Child and Adolescent Psychiatry 20050501 |
| The effect of erythromycin and fluvoxamine on the pharmacokinetics of intravenous lidocaine. | Anesthesia and analgesia 20050501 |
| Permanent deficits in serotonergic functioning of olfactory bulbectomized rats: an in vivo microdialysis study. | Biological psychiatry 20050501 |
| Severe diurnal somnolence induced by fluvoxamine-lithium combination. | Pharmacopsychiatry 20050501 |
| The difference between the formal and the functional dose: the case of the patient on thioridazine and fluvoxamine. | Journal of psychiatric practice 20050501 |
| AMPA receptor stimulation mediates the antidepressant-like effect of a group II metabotropic glutamate receptor antagonist. | Brain research 20050425 |
| Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: a functional magnetic resonance imaging study. | Biological psychiatry 20050415 |
| Low-dose fluvoxamine as an adjunct to reduce olanzapine therapeutic dose requirements: a prospective dose-adjusted drug interaction strategy. | Journal of clinical psychopharmacology 20050401 |
| Short-term combinational therapy of low-dose estrogen with selective serotonin re-uptake inhibitor (fluvoxamine) for oophorectomized women with hot flashes and depressive tendencies. | The journal of obstetrics and gynaecology research 20050401 |
| Photo-isomerization of fluvoxamine in aqueous solutions. | Journal of pharmaceutical and biomedical analysis 20050401 |
| Neuroleptic malignant syndrome induced by quetiapine and fluvoxamine. | The American journal of psychiatry 20050401 |
| Long-term course and outcome of obsessive-compulsive patients after cognitive-behavioral therapy in combination with either fluvoxamine or placebo: a 7-year follow-up of a randomized double-blind trial. | European archives of psychiatry and clinical neuroscience 20050401 |
| Interaction of a selective serotonin reuptake inhibitor with insulin in the control of hepatic glucose uptake in conscious dogs. | American journal of physiology. Endocrinology and metabolism 20050301 |
| Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors. | British journal of pharmacology 20050301 |
| Improvement of dry mouth by replacing paroxetine with fluvoxamine. | The Annals of pharmacotherapy 20050301 |
| Effects of fluvoxamine on levels of dopamine, serotonin, and their metabolites in the hippocampus elicited by isolation housing and novelty stress in adult rats. | The International journal of neuroscience 20050301 |
| Neuroendocrine (HPA axis) and clinical correlates during fluvoxamine and amitriptyline treatment. | Psychiatry research 20050227 |
| Decreased thalamic blood flow in obsessive-compulsive disorder patients responding to fluvoxamine. | Psychiatry research 20050227 |
| Determination of fluvoxamine and its metabolite fluvoxamino acid by liquid-liquid extraction and column-switching high-performance liquid chromatography. | Journal of pharmaceutical and biomedical analysis 20050207 |
| A sensitive HPLC method for the determination of fluoxetine and norfluoxetine in human plasma with fluorescence detection. | Therapeutic drug monitoring 20050201 |
| Nature, assessment, and treatment of generalized anxiety disorder in children. | Pediatric annals 20050201 |
| Fluvoxamine, a selective serotonin reuptake inhibitor, suppresses tetrahydrobiopterin levels and dopamine as well as serotonin turnover in the mesoprefrontal system of mice. | Psychopharmacology 20050101 |
| Sulpiride in combination with fluvoxamine increases in vivo dopamine release selectively in rat prefrontal cortex. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050101 |
| Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20050101 |
| A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression. | Pharmacopsychiatry 20050101 |
| Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study. | Clinical neuropharmacology 20050101 |
| Family-oriented rehabilitation for unexplained chronic pain. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20050101 |
| Fluvoxamine induced complex partial seizure in the treatment of bulimia nervosa. | General hospital psychiatry 20050101 |
| Pharmacological treatments of pathological gambling. | Journal of gambling studies 20050101 |
| A randomized controlled trial of Japanese patients with obsessive-compulsive disorder--effectiveness of behavior therapy and fluvoxamine. | Psychotherapy and psychosomatics 20050101 |
| [Case of obsessive-compulsive disorder associated with neuroleptics-induced deficit syndrome (NIDS): successfully treated by discontinuation of neuroleptics followed by SSRI]. | Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20050101 |
| Treatment of bulimia nervosa with fluvoxamine: a randomized controlled trial. | Advances in therapy 20050101 |
| Antidepressant apathy syndrome. | Perspectives in psychiatric care 20050101 |
| Reliability and validity of the pathological gambling adaptation of the Yale-Brown Obsessive-Compulsive Scale (PG-YBOCS). | Journal of gambling studies 20050101 |
| Neurological soft signs as predictors of treatment response to selective serotonin reuptake inhibitors in obsessive-compulsive disorder. | The Journal of neuropsychiatry and clinical neurosciences 20050101 |
| Immediate switching of antidepressant therapy: results from a clinical trial of duloxetine. | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20050101 |
| Portal infusion of a selective serotonin reuptake inhibitor enhances hepatic glucose disposal in conscious dogs. | American journal of physiology. Endocrinology and metabolism 20041201 |
| The C(-1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings. | The international journal of neuropsychopharmacology 20041201 |
| The advantages of choosing antiobsessive therapy according to decision-making functioning. | Journal of clinical psychopharmacology 20041201 |
| Dose-dependent alternations in the pharmacokinetics of olanzapine during coadministration of fluvoxamine in patients with schizophrenia. | Journal of clinical pharmacology 20041201 |
| Multiple-dose pharmacokinetics of fluvoxamine in children and adolescents. | Journal of the American Academy of Child and Adolescent Psychiatry 20041201 |
| Effects of concomitant fluvoxamine on the plasma concentration of etizolam in Japanese psychiatric patients: wide interindividual variation in the drug interaction. | Therapeutic drug monitoring 20041201 |
| Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial. | Archives of general psychiatry 20041201 |
| Characterization of the anxiolytic-like effects of fluvoxamine, milnacipran and risperidone in mice using the conditioned fear stress paradigm. | European journal of pharmacology 20041103 |
| Synergistic dopamine increase in the rat prefrontal cortex with the combination of quetiapine and fluvoxamine. | Psychopharmacology 20041101 |
| Effects of fluvoxamine on lansoprazole pharmacokinetics in relation to CYP2C19 genotypes. | Journal of clinical pharmacology 20041101 |
| Differential effects of milnacipran, fluvoxamine and paroxetine for inhibited and agitated depression. | European psychiatry : the journal of the Association of European Psychiatrists 20041101 |
| Comparison of two-phase treatment with imipramine or fluvoxamine, both followed by lithium addition, in inpatients with major depressive disorder. | The American journal of psychiatry 20041101 |
| Beta-arrestin-1 levels: reduced in leukocytes of patients with depression and elevated by antidepressants in rat brain. | The American journal of psychiatry 20041101 |
| Drug interaction of tizanidine and fluvoxamine. | Clinical pharmacology and therapeutics 20041101 |
| In vivo identification and characterization of binding sites for selective serotonin reuptake inhibitors in mouse brain. | Life sciences 20041029 |
| A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients. | Psychopharmacology 20041001 |
| Cost and effectiveness of venlafaxine extended-release and selective serotonin reuptake inhibitors in the acute phase of outpatient treatment for major depressive disorder. | Journal of clinical psychopharmacology 20041001 |
| Fluvoxamine and graded psychotherapy in the treatment of bulimia nervosa: a randomized, double-blind, placebo-controlled, multicenter study of short-term and long-term pharmacotherapy combined with a stepped care approach to psychotherapy. | Journal of clinical psychopharmacology 20041001 |
| Selective serotonin re-uptake inhibitor augmentation in the treatment of negative symptoms of schizophrenia. | Expert opinion on pharmacotherapy 20041001 |
| Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors. | The Journal of clinical psychiatry 20041001 |
| [Case report of pentazocine dependence from a standpoint of the cognitive therapy]. | Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence 20041001 |
| Patients with obsessive-compulsive disorder (OCD) displayed cognitive deficits consistent with a dysfunction of the dorsolateral-striatal circuit. | Psychological medicine 20041001 |
| Depression in general clinical practice. | Journal of the Indian Medical Association 20041001 |
| Treating functional impairment of autism with selective serotonin-reuptake inhibitors. | The Annals of pharmacotherapy 20040901 |
| CYP2B6, CYP3A4, and CYP2C19 are responsible for the in vitro N-demethylation of meperidine in human liver microsomes. | Drug metabolism and disposition: the biological fate of chemicals 20040901 |
| Antidepressant-like effect of tramadol and its enantiomers in reserpinized mice: comparative study with desipramine, fluvoxamine, venlafaxine and opiates. | Journal of psychopharmacology (Oxford, England) 20040901 |
| Acute and chronic toxicity of five selective serotonin reuptake inhibitors in Ceriodaphnia dubia. | Environmental toxicology and chemistry 20040901 |
| Influence of hot flashes on quality of life in patients with prostate cancer treated with androgen deprivation therapy. | International journal of urology : official journal of the Japanese Urological Association 20040901 |
| [Two cases of adult Down syndrome treated with selective serotonin re-uptake inhibitor for behavior disorders]. | No to hattatsu = Brain and development 20040901 |
| Further evidence of a combined effect of SERTPR and TPH on SSRIs response in mood disorders. | American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 20040815 |
| Ephedra alkaloids and brief relapse in EMDR-treated obsessive compulsive disorder. | Acta psychiatrica Scandinavica 20040801 |
| Olanzapine plus fluvoxamine and olanzapine alone for the treatment of an acute exacerbation of schizophrenia. | Psychiatry and clinical neurosciences 20040801 |
| Chronic treatment with fluvoxamine desensitizes 5-HT2C receptor-mediated hypolocomotion in rats. | Pharmacology, biochemistry, and behavior 20040801 |
| Differential effects of fluvoxamine, paroxetine and milnacipran for depression, especially with regard to age. | Human psychopharmacology 20040801 |
| The differential effects of steady-state fluvoxamine on the pharmacokinetics of olanzapine and clozapine in healthy volunteers. | Journal of clinical pharmacology 20040701 |
| [Analysis and its application for prevention of side-effects of drugs and for evaluation of drug responsiveness]. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20040601 |
| Late onset OCD. | The Australian and New Zealand journal of psychiatry 20040601 |
| Neonatal complications after intrauterine exposure to SSRI antidepressants. | Prescrire international 20040601 |
| Adjunctive fluvoxamine inhibits clozapine-related weight gain and metabolic disturbances. | The Journal of clinical psychiatry 20040601 |
| Antipsychotic-associated weight gain. | The Annals of pharmacotherapy 20040501 |
| Long-term sequestration of fluorinated compounds in tissues after fluvoxamine or fluoxetine treatment: a fluorine magnetic resonance spectroscopy study in vivo. | Magma (New York, N.Y.) 20040501 |
| Acquired factor XIII deficiency due to an inhibitor: a case report and review of the literature. | Haematologica 20040501 |
| 'Compulsive' lever-pressing in rats is attenuated by the serotonin re-uptake inhibitors paroxetine and fluvoxamine but not by the tricyclic antidepressant desipramine or the anxiolytic diazepam. | Behavioural pharmacology 20040501 |
| Efficacy of fluvoxamine in preventing relapse in alcohol dependence: a one-year, double-blind, placebo-controlled multicentre study with analysis by typology. | Drug and alcohol dependence 20040409 |
| Efficacy and pharmacokinetics of fluvoxamine maleate in patients with mild depression undergoing hemodialysis. | Psychiatry and clinical neurosciences 20040401 |
| Different inhibitory effect of fluvoxamine on omeprazole metabolism between CYP2C19 genotypes. | British journal of clinical pharmacology 20040401 |
| Fluvoxamine drastically increases concentrations and effects of tizanidine: a potentially hazardous interaction. | Clinical pharmacology and therapeutics 20040401 |
| Induction of diphenytriazol on cytochrome CYP1A. | Acta pharmacologica Sinica 20040401 |
| A comparative solid-phase extraction study for the simultaneous determination of fluvoxamine, mianserin, doxepin, citalopram, paroxetine, and etoperidone in whole blood by capillary gas-liquid chromatography with nitrogen-phosphorus detection. | Journal of analytical toxicology 20040401 |
| [Postherpetic neuralgia alleviated by an SSRI fluvoxamine: two cases of PHN accompanied with depression were treated with fluvoxamine]. | Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20040401 |
| [Dysfunction of serotonergic systems in thiamine-deficient diet fed mice: effects of SSRI on abnormality induced by thiamine deficiency]. | Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20040401 |
| Fluvoxamine-controlled release formulation for the treatment of generalized social anxiety disorder. | Journal of clinical psychopharmacology 20040401 |
| Increased cell proliferation in the adult mouse hippocampus following chronic administration of group II metabotropic glutamate receptor antagonist, MGS0039. | Biochemical and biophysical research communications 20040305 |
| Fluvoxamine, a selective serotonin reuptake inhibitor, suppresses tetrahydrobiopterin in the mouse hippocampus. | Neuropharmacology 20040301 |
| The effects of selective serotonin-reuptake inhibitor on visual evoked potential in rats. | Journal of pharmacological sciences 20040301 |
| A double-blind placebo-controlled study of controlled release fluvoxamine for the treatment of generalized social anxiety disorder. | Journal of clinical psychopharmacology 20040201 |
| [Effect of concurrent treatment of SSRI on the tyrosine hydroxylase immunoreactivity in the rat locus coeruleus treated with chronic variable stress]. | Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology 20040201 |
| Overvalued ideation as a predictor of fluvoxamine response in patients with obsessive-compulsive disorder. | Psychiatry research 20040130 |
| Fluvoxamine dose-dependent interaction with haloperidol and the effects on negative symptoms in schizophrenia. | Psychopharmacology 20040101 |
| Serotonin uptake and metabolism by cultured guinea pig airway smooth muscle cells. | Pulmonary pharmacology & therapeutics 20040101 |
| Insight in obsessive compulsive disorder and body dysmorphic disorder. | Comprehensive psychiatry 20040101 |
| Different effects of selective serotonin reuptake inhibitors on a patient suffering from panic disorder. | Human psychopharmacology 20040101 |
| Efficacy of fluvoxamine as a treatment for behavioral symptoms in frontotemporal lobar degeneration patients. | Dementia and geriatric cognitive disorders 20040101 |
| Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function. | Clinical pharmacology and therapeutics 20040101 |
| Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder. | Pharmacopsychiatry 20040101 |
| Homeopathic remedies as placebo alternatives--verification on the example of treatment of menopause-related vegetative and emotional disturbances. | Science and engineering ethics 20040101 |
| The effects of a 5-hydroxytryptamine 1A receptor gene polymorphism on the clinical response to fluvoxamine in depressed patients. | The pharmacogenomics journal 20040101 |
| [Selective serotonin reuptake inhibitors--current knowledge]. | Psychiatria polska 20040101 |
| Fluvoxamine for fatigue in primary biliary cirrhosis and primary sclerosing cholangitis: a randomised controlled trial [ISRCTN88246634]. | BMC gastroenterology 20040101 |
| [Estimation of therapeutical efficacy of weak variable magnetic fields with low value of induction in patients with depression]. | Psychiatria polska 20040101 |
| Coexistent hypothyroidism, psychosis, and severe obsessions in an adolescent: a 10-year follow-up. | Journal of child and adolescent psychopharmacology 20040101 |
| Fluvoxamine treatment of major depression associated with multiple sclerosis. | The Journal of neuropsychiatry and clinical neurosciences 20040101 |
| Depression, anxiety, anger, and somatic symptoms in patients with body dysmorphic disorder. | The Psychiatric quarterly 20040101 |
| Influence of antidepressant drugs on macrophage cytotoxic activity in rats. | Polish journal of pharmacology 20040101 |
| [Review of double-blind studies comparing SSRI and SNRI]. | Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica 20040101 |
| Evaluation of double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients in menopause transition. | Journal of medicine 20040101 |
| In vitro metabolism of zolmitriptan in rat cytochromes induced with beta-naphthoflavone and the interaction between six drugs and zolmitriptan. | Chemico-biological interactions 20031215 |
| Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12- to 24-week extension phase of a multicentre, randomized, placebo-controlled trial. | The international journal of neuropsychopharmacology 20031201 |
| Interaction study between fluvoxamine and quazepam. | Journal of clinical pharmacology 20031201 |
| Comparison of response to fluvoxamine in nondemented elderly compared to younger patients affected by major depression. | Journal of clinical psychopharmacology 20031201 |
| Treatment of pathological gambling: a critical review of the literature. | Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors 20031201 |
| Relationship between fluvoxamine and stress barometer for nocturnal enuresis. | Pediatrics international : official journal of the Japan Pediatric Society 20031201 |
| Differential effects of milnacipran, fluvoxamine and paroxetine for depression, especially in gender. | European psychiatry : the journal of the Association of European Psychiatrists 20031201 |
| Joint regression and association modeling of longitudinal ordinal data. | Biometrics 20031201 |
| Interactions of acute morphine with chronic imipramine and fluvoxamine treatment on the antinociceptive effect in arthritic rats. | Neuroscience letters 20031127 |
| Pharmacokinetic and pharmacodynamic interactions of oral midazolam with ketoconazole, fluoxetine, fluvoxamine, and nefazodone. | Journal of clinical pharmacology 20031101 |
| Serotonin (5-HT) transporter (SERT) function after graded destruction of serotonergic neurons. | Journal of neurochemistry 20031101 |
| [Improved method of fluvoxamine synthesis]. | Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20031001 |
| Metabolism and elimination of quinine in healthy volunteers. | European journal of clinical pharmacology 20030901 |
| Successful electroconvulsive therapy in major depression with fluvoxamine-induced bruxism. | The journal of ECT 20030901 |
| [Anxiety in school refusal children with indefinite complaints: psychological estimation using State-Trait Anxiety Inventory and therapy by serotonin reuptake inhibitors]. | No to hattatsu = Brain and development 20030901 |
| Trichotillomania: a review and case report. | Cutis 20030901 |
| Blockade of serotonin 5-HT1B and 5-HT2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes. | Psychopharmacology 20030801 |
| Re: The efficacy and safety of oral desmopressin in children with primary nocturnal enuresis. | The Journal of urology 20030801 |
| Effects of the CYP 2D6 genotype and cigarette smoking on the steady-state plasma concentrations of fluvoxamine and its major metabolite fluvoxamino acid in Japanese depressed patients. | Therapeutic drug monitoring 20030801 |
| Methylphenidate-induced obsessive-compulsive symptoms in an elderly man. | CNS spectrums 20030801 |
| Grapefruit juice-fluvoxamine interaction--is it risky or not? | Journal of clinical psychopharmacology 20030801 |
| Schneiderian first-rank symptoms associated with fluvoxamine treatment: a case report. | Human psychopharmacology 20030801 |
| Differential period of onset of action of fluvoxamine, paroxetine and milnacipran for depression. | Human psychopharmacology 20030801 |
| Exaggerated effect of fluvoxamine in heterozygote serotonin transporter knockout mice. | Journal of neurochemistry 20030701 |
| Drug binding to HERG channels: evidence for a 'non-aromatic' binding site for fluvoxamine. | British journal of pharmacology 20030701 |
| Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652. | British journal of pharmacology 20030701 |
| Fluvoxamine versus fluoxetine in major depressive episode: a double-blind randomised comparison. | Human psychopharmacology 20030701 |
| [Effect of selective serotonin reuptake inhibitor on the chronic rumination and vomiting of a severely handicapped patient]. | No to hattatsu = Brain and development 20030701 |
| Relationship between clinical effects of fluvoxamine and the steady-state plasma concentrations of fluvoxamine and its major metabolite fluvoxamino acid in Japanese depressed patients. | Psychopharmacology 20030601 |
| A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder. | The Journal of clinical psychiatry 20030601 |
| Changes in synaptic properties in cortical-limbic communications induced by repeated treatments with fluvoxamine in rats. | Journal of pharmacological sciences 20030601 |
| High-performance liquid chromatographic determination of fluvoxamine and fluvoxamino acid in human plasma. | Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20030601 |
| Assessment of safety in pediatric psychopharmacology. | Journal of the American Academy of Child and Adolescent Psychiatry 20030601 |
| A local influence approach applied to binary data from a psychiatric study. | Biometrics 20030601 |
| [Obsessive-compulsive disorders in general practice. How the obsessive-compulsive neurotic is revealed by skin and hair]. | MMW Fortschritte der Medizin 20030526 |
| Fluvoxamine modulates pain sensation and affective processing of pain in human brain. | Neuroreport 20030506 |
| Role of extracellular serotonin levels in the effect of 5-HT1B receptor blockade. | Psychopharmacology 20030501 |
| Comparison of in vitro and in vivo inhibition potencies of fluvoxamine toward CYP2C19. | Drug metabolism and disposition: the biological fate of chemicals 20030501 |
| Fluvoxamine therapy for fibromyalgia. | The Journal of rheumatology 20030501 |
| Quinine 3-hydroxylation as a biomarker reaction for the activity of CYP3A4 in man. | European journal of clinical pharmacology 20030501 |
| [Studies on the adverse effects of fluvoxamine treatment in children with autistic disorder: correlation with genetic polymorphism in serotonin related genes]. | No to hattatsu = Brain and development 20030501 |
| [A five-year-old girl with epilepsy showing forced normalization due to zonisamide]. | No to hattatsu = Brain and development 20030501 |
| Long-term efficacy of exposure and ritual prevention therapy and serotonergic medications for obsessive-compulsive disorder. | CNS spectrums 20030501 |
| Effects of selective serotonin reuptake inhibitors on immobility time in the tail suspension test in streptozotocin-induced diabetic mice. | Pharmacology, biochemistry, and behavior 20030501 |
| Inhibition of P-glycoprotein by newer antidepressants. | The Journal of pharmacology and experimental therapeutics 20030401 |
| Suitable dose and duration of fluvoxamine administration to treat depression. | Psychiatry and clinical neurosciences 20030401 |
| Possible predictors of response to fluvoxamine for depression. | Human psychopharmacology 20030401 |
| High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography. | Archives of general psychiatry 20030401 |
| Effects of concomitant fluvoxamine on the metabolism of alprazolam in Japanese psychiatric patients: interaction with CYP2C19 mutated alleles. | European journal of clinical pharmacology 20030401 |
| A double-blind, placebo-controlled trial of fluvoxamine in binge eating disorder: a high placebo response. | Archives of women's mental health 20030401 |
| Study and analytical application of ion-pair formation in the system fluoxetine-pyrocatechol violet and fluvoxamine-pyrocatechol violet. | Die Pharmazie 20030401 |
| Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography. | Journal of medicinal chemistry 20030313 |
| Fluvoxamine as effective as clomipramine against symptoms of severe depression: results from a multicentre, double-blind study. | Human psychopharmacology 20030301 |
| The onset and time course of response of negative symptoms to add-on fluvoxamine treatment. | International clinical psychopharmacology 20030301 |
| Selective serotonin reuptake inhibitors enhance cocaine-induced locomotor activity and dopamine release in the nucleus accumbens. | Neuropharmacology 20030301 |
| Manic-switch induced by fluvoxamine in abstinent pure methamphetamine abusers. | Journal of psychiatry & neuroscience : JPN 20030301 |
| Emerging skin-picking behaviour after serotonin reuptake inhibitor-treatment in patients with obsessive-compulsive disorder: possible mechanisms and implications for clinical care. | Journal of psychopharmacology (Oxford, England) 20030301 |
| Inhibition of G protein-activated inwardly rectifying K+ channels by fluoxetine (Prozac). | British journal of pharmacology 20030301 |
| [Post-stroke depression]. | Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics 20030301 |
| Fluvoxamine-induced hyperglycaemia in a diabetic patient with comorbid depression. | The international journal of neuropsychopharmacology 20030301 |
| Serotonergic signaling inhibits hyperalgesia induced by spinal cord damage. | Brain research 20030214 |
| Strategies to decrease costs of prescribing selective serotonin reuptake inhibitors at a VA Medical Center. | Psychiatric services (Washington, D.C.) 20030201 |
| An evaluation of the effect of NAS-181, a new selective 5-HT(1B) receptor antagonist, on extracellular 5-HT levels in rat frontal cortex. | Naunyn-Schmiedeberg's archives of pharmacology 20030201 |
| Drug-related hyperprolactinemia. | Prescrire international 20030201 |
| CYP2D6*10 alleles do not determine plasma fluvoxamine concentration/dose ratio in Japanese subjects. | European journal of clinical pharmacology 20030201 |
| Possible involvement of peripheral serotonin 5-HT3 receptors in fluvoxamine-induced emesis in Suncus murinus. | The Journal of pharmacy and pharmacology 20030201 |
| Antidepressant response and fluvoxamine plasma concentrations: a pilot study. | Pharmacy world & science : PWS 20030201 |
| Low-dose fluvoxamine treatment of children and adolescents with pervasive developmental disorders: a prospective, open-label study. | Journal of autism and developmental disorders 20030201 |
| Fluvoxamine suppresses the long-term potentiation in the hippocampal CA1 field of anesthetized rats: an effect mediated via 5-HT1A receptors. | Brain research 20030103 |
| Fluvoxamine reduces responsiveness of HPA axis in adult female BPD patients with a history of sustained childhood abuse. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20030101 |
| Searching for moderators and mediators of pharmacological treatment effects in children and adolescents with anxiety disorders. | Journal of the American Academy of Child and Adolescent Psychiatry 20030101 |
| Adjunctive fluvoxamine with clozapine. | The British journal of psychiatry : the journal of mental science 20030101 |
| [Serotonin 2A receptor gene polymorphism and clinical efficacy of fluvoxamine in children with autistic disorder]. | No to hattatsu = Brain and development 20030101 |
| [Comparative efficacy and tolerance of fluvoxamine and amitriptyline in the treatment of moderate and severe depression in mental hospital]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20030101 |
| An open trial of fluvoxamine for hypochondriasis. | Psychosomatics 20030101 |
| [Double depression]. | Ryoikibetsu shokogun shirizu 20030101 |
| [Pharmacokinetics and drug interaction of antidepressants and anti-manic drugs]. | Ryoikibetsu shokogun shirizu 20030101 |
| [Serotonin syndrome]. | Ryoikibetsu shokogun shirizu 20030101 |
| [Panic disorder and agoraphobia]. | Ryoikibetsu shokogun shirizu 20030101 |
| [The treatment of OCD]. | Ryoikibetsu shokogun shirizu 20030101 |
| [Compulsion(ritual)]. | Ryoikibetsu shokogun shirizu 20030101 |
| [Eating disorders]. | Ryoikibetsu shokogun shirizu 20030101 |
| The use of sumatriptan in the treatment of obsessive-compulsive disorder in an adolescent. | Journal of child and adolescent psychopharmacology 20030101 |
| Monoamine oxidase A gene polymorphism, 5-HT 2A receptor gene polymorphism and incidence of nausea induced by fluvoxamine. | Neuropsychobiology 20030101 |
| [The usage of different antidepressants in therapy of obsessive-compulsive disorders]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20030101 |
| Add-on fluvoxamine improves primary negative symptoms: evidence for specificity from response analysis of individual symptoms. | Schizophrenia bulletin 20030101 |
| [Obsessive-compulsive disorder in childhood and adolescence]. | Ryoikibetsu shokogun shirizu 20030101 |
| Effects of fluvoxamine, a selective serotonin re-uptake inhibitor, on serotonin release from the mouse isolated ileum. | Research communications in molecular pathology and pharmacology 20030101 |
| Differential effects of the 5-HT2 receptor antagonist on the anti-immobility effects of noradrenaline and serotonin reuptake inhibitors in the forced swimming test. | Brain research 20021220 |
| Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression. | Biological psychiatry 20021215 |
| SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. | The American journal of psychiatry 20021201 |
| Fluvoxamine interaction with warfarin. | The Annals of pharmacotherapy 20021201 |
| Dosing strategies of clozapine-fluvoxamine cotreatment. | Journal of clinical psychopharmacology 20021201 |
| Consultation with the specialist: the central serotonin syndrome: paradigm for psychotherapeutic misadventure. | Pediatrics in review 20021201 |
| Monoamine oxidase: A gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder. | Progress in neuro-psychopharmacology & biological psychiatry 20021201 |
| Fluvoxamine treatment of a Japanese patient with koro. | The Journal of clinical psychiatry 20021201 |
| Antipsychotic, antidepressant, anxiolytic, and anticonvulsant drugs induce type II nitric oxide synthase mRNA in rat brain. | Neuroscience letters 20021129 |
| Comparison of the anticholinergic effects of the serotonergic antidepressants, paroxetine, fluvoxamine and clomipramine. | European journal of pharmacology 20021115 |
| Predictors of fluvoxamine response in contamination-related obsessive compulsive disorder: a PET symptom provocation study. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20021101 |
| No association between the serotonergic polymorphisms and incidence of nausea induced by fluvoxamine treatment. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20021001 |
| Fluvoxamine augmentation of olanzapine in chronic schizophrenia: pharmacokinetic interactions and clinical effects. | Journal of clinical psychopharmacology 20021001 |
| Comments on in vitro and in vivo studies of fluvoxamine-clozapine interaction. | Journal of clinical psychopharmacology 20021001 |
| Reduction of central poststroke pain with the selective serotonin reuptake inhibitor fluvoxamine. | The International journal of neuroscience 20021001 |
| Changes in synaptic plasticity in the rat hippocampo-medial prefrontal cortex pathway induced by repeated treatments with fluvoxamine. | Brain research 20020913 |
| Plasma levels of catecholamine metabolites predict the response to sulpiride or fluvoxamine in major depression. | Pharmacopsychiatry 20020901 |
| A randomized controlled trial of fluvoxamine in prostatodynia, a male somatoform pain disorder. | The Journal of clinical psychiatry 20020901 |
| Obsessive-compulsive disorder with non-24-hour sleep-wake syndrome. | The Journal of clinical psychiatry 20020901 |
| Photoisomerization of fluvoxamine generates an isomer that has reduced activity on the 5-hydroxytryptamine transporter and does not affect cell proliferation. | European journal of pharmacology 20020830 |
| A variable number of tandem repeats in the serotonin transporter gene does not affect the antidepressant response to fluvoxamine. | Psychiatry research 20020830 |
| Serotonin agents in the treatment of acquired brain injury. | The Journal of head trauma rehabilitation 20020801 |
| Block of volume-regulated anion channels by selective serotonin reuptake inhibitors. | Naunyn-Schmiedeberg's archives of pharmacology 20020801 |
| 24-Hour motor activity after treatment with imipramine or fluvoxamine in major depressive disorder. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20020801 |
| Fluvoxamine-clozapine interaction: time-dependent? | Journal of clinical psychopharmacology 20020801 |
| Extracellular serotonin in the prefrontal cortex is limited through terminal 5-HT(1B) autoreceptors: a microdialysis study in knockout mice. | Psychopharmacology 20020801 |
| CYP2D6 inhibition by selective serotonin reuptake inhibitors: analysis of achievable steady-state plasma concentrations and the effect of ultrarapid metabolism at CYP2D6. | Pharmacotherapy 20020801 |
| An open pilot study combining risperidone and a selective serotonin reuptake inhibitor as initial antidepressant therapy. | The Journal of clinical psychiatry 20020801 |
| Serum cholesterol level comparison: control subjects, anxiety disorder patients, and obsessive-compulsive disorder patients. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20020801 |
| Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats. | Psychopharmacology 20020701 |
| [A case of Klüver-Bucy syndrome after acute encephalopathy treated with selective serotonin reuptake inhibitor (fluvoxamine)]. | No to hattatsu = Brain and development 20020701 |
| The effect of fluvoxamine and sertraline on the opioid withdrawal syndrome: a combined in vivo cerebral microdialysis and behavioural study. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20020601 |
| Changes in serotonin, serotonin transporter expression and serotonin denervation supersensitivity: involvement in chronic central pain after spinal hemisection in the rat. | Experimental neurology 20020601 |
| Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders. | The American journal of psychiatry 20020501 |
| [Treatment with fluvoxamine against self-injury and aggressive behavior in autistic children]. | No to hattatsu = Brain and development 20020501 |
| The amount of fluvoxamine in milk is unlikely to be a cause of adverse effects in breastfed infants. | Journal of human lactation : official journal of International Lactation Consultant Association 20020501 |
| Fluvoxamine: safety profile in extensive post-marketing surveillance. | Pharmacopsychiatry 20020501 |
| Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells. | The Journal of biological chemistry 20020419 |
| The effects of selective serotonin reuptake inhibitors on extracellular 5-HT levels in the hippocampus of 5-HT(1B) receptor knockout mice. | European journal of pharmacology 20020329 |
| Musical hallucinations and deafness: a case report and review of the literature. | Neuropsychiatry, neuropsychology, and behavioral neurology 20020301 |
| Credibility of problem-solving therapy and medication for the treatment of depression among primary care patients. | Medical science monitor : international medical journal of experimental and clinical research 20020301 |
| The selective serotonin re-uptake inhibitors fluvoxamine and paroxetine differ in sexual inhibitory effects after chronic treatment. | Psychopharmacology 20020301 |
| Differential effects of milnacipran and fluvoxamine, especially in patients with severe depression and agitated depression: a case-control study. | International clinical psychopharmacology 20020301 |
| Neurotoxic syndrome associated with risperidone and fluvoxamine. | The Annals of pharmacotherapy 20020301 |
| Low daily 10-mg and 20-mg doses of fluvoxamine inhibit the metabolism of both caffeine (cytochrome P4501A2) and omeprazole (cytochrome P4502C19). | Clinical pharmacology and therapeutics 20020301 |
| A pilot placebo-controlled study of fluvoxamine for pathological gambling. | Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 20020301 |
| Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity. | The international journal of neuropsychopharmacology 20020301 |
| Fluvoxamine augmentation in risperidone-resistant schizophrenia: an open trial. | Human psychopharmacology 20020301 |
| Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients. | Progress in neuro-psychopharmacology & biological psychiatry 20020201 |
| Diagnosis at the first episode to differentiate antidepressant treatment responses in patients with mood and anxiety disorders. | Psychopharmacology 20020201 |
| Mirtazapine, but not fluvoxamine, normalizes the blunted REM sleep response to clonidine in depressed patients: implications for subsensitivity of alpha(2)-adrenergic receptors in depression. | Psychiatry research 20020131 |
| An 8-year-old boy with autism, 1 year later. | JAMA 20020101 |
| Interaction between fluvoxamine and cotinine or caffeine. | Neuropsychobiology 20020101 |
| Fluvoxamine treatment in veterans with combat-related post-traumatic stress disorder. | Depression and anxiety 20020101 |
| Spotlight on fluvoxamine in anxiety disorders in children and adolescents. | CNS drugs 20020101 |
| The light-enhanced startle paradigm as a putative animal model for anxiety: effects of chlordiazepoxide, flesinoxan and fluvoxamine. | Psychopharmacology 20020101 |
| [A case of fluvoxamine overdose]. | Chudoku kenkyu : Chudoku Kenkyukai jun kikanshi = The Japanese journal of toxicology 20020101 |
| Response to fluvoxamine augmentation for obsessive and compulsive symptoms in schizophrenia. | Journal of child and adolescent psychopharmacology 20020101 |
| Refractory obsessive-compulsive disorder: state-of-the-art treatment. | The Journal of clinical psychiatry 20020101 |
| [Evaluation of analgesic action of fluvoxamine compared with efficacy of imipramine and tramadol for treatment of sciatica--open trial]. | Wiadomosci lekarskie (Warsaw, Poland : 1960) 20020101 |
| Obsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment response. | The pharmacogenomics journal 20020101 |
| Delayed recurrent SIADH associated with SSRIs. | The Annals of pharmacotherapy 20020101 |
| Comment: neuroleptic malignant syndrome associated with risperidone and fluvoxamine. | The Annals of pharmacotherapy 20020101 |
| Pharmacokinetics of fluvoxamine in relation to CYP2C19 phenotype and genotype. | Drug metabolism and drug interactions 20020101 |
| [Methods of determination of fluoxetine nad fluvoxamine]. | Psychiatria polska 20020101 |
| [A case of amyotrophic lateral sclerosis with SIADH and throbbing headache induced by selective serotonin reuptake inhibitor]. | Rinsho shinkeigaku = Clinical neurology 20020101 |
| CPT performance in major depressive disorder before and after treatment with imipramine or fluvoxamine. | Journal of psychiatric research 20020101 |
| Association between -1438G/A promoter polymorphism in the 5-HT(2A) receptor gene and fluvoxamine response in Japanese patients with major depressive disorder. | Neuropsychobiology 20020101 |
| Treatment of pediatric anxiety disorders: an open-label extension of the research units on pediatric psychopharmacology anxiety study. | Journal of child and adolescent psychopharmacology 20020101 |
| [Prognostic value of pharmaco-EEG in depression treated with fluvoxamine]. | Psychiatria polska 20020101 |
| Treatment-resistance to clozapine in association with ultrarapid CYP1A2 activity and the C-->A polymorphism in intron 1 of the CYP1A2 gene: effect of grapefruit juice and low-dose fluvoxamine. | Journal of clinical psychopharmacology 20011201 |
| Abnormalities of thermoregulation induced by fluvoxamine. | Journal of clinical psychopharmacology 20011201 |
| Differences between in vitro and in vivo determinations of fluvoxamine-clozapine interaction. | Journal of clinical psychopharmacology 20011201 |
| SSRIs associated with behavioral activation and suicidal ideation. | Journal of the American Academy of Child and Adolescent Psychiatry 20011201 |
| [Effects of fluvoxamine on both the desired anxiolytic effect and the adverse motor incoordination and amnesia induced by benzodiazepines]. | Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20011201 |
| Aggravation of glaucoma with fluvoxamine. | The Annals of pharmacotherapy 20011201 |
| Comment: serotonin syndrome induced by fluvoxamine and mirtazapine. | The Annals of pharmacotherapy 20011201 |
| Successful treatment of steroid-induced depression with low dosage of fluvoxamine. | The Australian and New Zealand journal of psychiatry 20011201 |
| No association between dopamine D(2) and D(4) receptor gene variants and antidepressant activity of two selective serotonin reuptake inhibitors. | Psychiatry research 20011130 |
| Characteristics of fluvoxamine-induced nausea. | Psychiatry research 20011130 |
| Fluvoxamine-theophylline interaction: gap between in vitro and in vivo inhibition constants toward cytochrome P4501A2. | Clinical pharmacology and therapeutics 20011101 |
| Fluvoxamine and perphenazine for psychosis in Alzheimer's disease: pharmacokinetic considerations. | The Journal of nervous and mental disease 20011101 |
| The major fluvoxamine metabolite in urine is formed by CYP2D6. | European journal of clinical pharmacology 20011101 |
| Aminophylline reversal of antihypertensive agent toxicity. | Veterinary and human toxicology 20011001 |
| Fluvoxamine for postpartum depression. | The American journal of psychiatry 20011001 |
| Clinical predictors of drug response in obsessive-compulsive disorder. | Journal of clinical psychopharmacology 20011001 |
| The effects of the selective serotonin reuptake-inhibitor fluvoxamine on body weight in Zucker rats are mediated by corticotropin-releasing hormone. | International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 20011001 |
| Serotonin syndrome induced by fluvoxamine and mirtazapine. | The Annals of pharmacotherapy 20011001 |
| Fluvoxamine augmentation increases serum mirtazapine concentrations three- to fourfold. | The Annals of pharmacotherapy 20011001 |
| A display of hypomania in a depressed male in response to fluvoxamine. | The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 20011001 |
| Repeated treatment with imipramine, fluvoxamine and tranylcypromine decreases the number of escape failures by activating dopaminergic systems in a rat learned helplessness test. | Life sciences 20010907 |
| The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain. | British journal of pharmacology 20010901 |
| Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity. | Molecular psychiatry 20010901 |
| Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression. | Biological psychiatry 20010901 |
| Violent acts associated with fluvoxamine treatment. | Journal of psychiatry & neuroscience : JPN 20010901 |
| Taijin kyofusho: a form of social anxiety disorder that responds to serotonin reuptake inhibitors? | The international journal of neuropsychopharmacology 20010901 |
| Physical exercise: an adjunctive treatment for panic disorder? | European psychiatry : the journal of the Association of European Psychiatrists 20010901 |
| Fluvoxamine for the treatment of anxiety disorders in children and adolescents. | The New England journal of medicine 20010809 |
| Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients. | Psychiatry research 20010805 |
| Effect of chronic administration of flesinoxan and fluvoxamine on freezing behavior induced by conditioned fear. | European journal of pharmacology 20010803 |
| Fluvoxamine and aggression in mental retardation. | Psychiatric services (Washington, D.C.) 20010801 |
| Fluvoxamine but not sertraline inhibits the metabolism of olanzapine: evidence from a therapeutic drug monitoring service. | Therapeutic drug monitoring 20010801 |
| Use of sertraline, paroxetine and fluvoxamine by nursing women. | The British journal of psychiatry : the journal of mental science 20010801 |
| More on fluvoxamine and enuresis. | Journal of the American Academy of Child and Adolescent Psychiatry 20010801 |
| Is fluvoxamine safe and effective for treating anxiety disorders in children? | The Journal of family practice 20010801 |
| [Pharmacokinetics and drug interactions of antidepressive agents]. | Nihon rinsho. Japanese journal of clinical medicine 20010801 |
| [Early internal treatment of mild depression]. | Nihon rinsho. Japanese journal of clinical medicine 20010801 |
| [Vascular depression]. | Nihon rinsho. Japanese journal of clinical medicine 20010801 |
| Effects of fluvoxamine and paroxetine on sleep structure in normal subjects: a home-based Nightcap evaluation during drug administration and withdrawal. | The Journal of clinical psychiatry 20010801 |
| Detailed characterization of experimentally derived human hepatic CYP1A1 activity and expression using differential inhibition of ethoxyresorufin O-deethylation by fluvoxamine. | European journal of clinical pharmacology 20010801 |
| Mild serotonin syndrome on fluvoxamine. | The International journal of neuroscience 20010801 |
| Aggravation of food-related behavior in an adolescent with Prader-Willi syndrome treated with fluvoxamine and fluoxetine. | The International journal of eating disorders 20010701 |
| [Treatment of panic disorder with combination of SSRI and cognitive-behavioral therapy]. | Psychiatrische Praxis 20010701 |
| Long-term follow-up and predictors of clinical outcome in obsessive-compulsive patients treated with serotonin reuptake inhibitors and behavioral therapy. | The Journal of clinical psychiatry 20010701 |
| [Clinical evaluation of treatment with fluvoxamine, a selective serotonin reuptake inhibitor in children with autistic disorder]. | No to hattatsu = Brain and development 20010701 |
| Fluvoxamine and sleep disturbances in posttraumatic stress disorder. | Journal of traumatic stress 20010701 |
| Effects of aging on serotonin transporter availability and its response to fluvoxamine in the living brain: PET study with [(11)C](+)McN5652 and [(11)C](-)McN5652 in conscious monkeys. | Synapse (New York, N.Y.) 20010601 |
| Noradrenergic function and clinical outcome in antidepressant pharmacotherapy. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20010601 |
| Effects of fluvoxamine on ethanol-reinforced behavior in the rat. | The Journal of pharmacology and experimental therapeutics 20010601 |
| SSRIs and mammoplasia. | The American journal of psychiatry 20010601 |
| Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder. | Journal of clinical psychopharmacology 20010601 |
| SSRI treatment suppresses dream recall frequency but increases subjective dream intensity in normal subjects. | Journal of sleep research 20010601 |
| Use of midazolam urinary metabolic ratios for cytochrome P450 3A (CYP3A) phenotyping. | Pharmacogenetics 20010601 |
| Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism. | European journal of pharmacology 20010518 |
| The luvox debate. | Time 20010507 |
| Antidepressant efficacy and tolerability of milnacipran, a dual serotonin and noradrenaline reuptake inhibitor: a comparison with fluvoxamine. | International clinical psychopharmacology 20010501 |
| A comparative pharmacodynamic study of the arrhythmogenicity of antidepressants, fluvoxamine and imipramine, in guinea pigs. | Biological & pharmaceutical bulletin 20010501 |
| Interaction of olanzapine with fluvoxamine. | Psychopharmacology 20010501 |
| A case of pathological gambling--its features and mangement. | Singapore medical journal 20010501 |
| Drug treatment of anxiety disorders in children. | The New England journal of medicine 20010426 |
| Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group. | The New England journal of medicine 20010426 |
| Fluvoxamine treatment of mixed anxiety and depression: evidence for serotonergically mediated anxiolysis. | Journal of clinical psychopharmacology 20010401 |
| Differential effects of fluvoxamine and other antidepressants on the biotransformation of melatonin. | Journal of clinical psychopharmacology 20010401 |
| Effects of fluconazole and fluvoxamine on the pharmacokinetics and pharmacodynamics of glimepiride. | Clinical pharmacology and therapeutics 20010401 |
| Noradrenergic dysfunction and antidepressant treatment response. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20010401 |
| A case of resistant trichotillomania treated with risperidone-augmented fluvoxamine. | Canadian journal of psychiatry. Revue canadienne de psychiatrie 20010401 |
| Increased libido in a woman treated with fluvoxamine: a case report. | Acta psychiatrica Scandinavica 20010401 |
| The effect of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics and metabolism of perazine in the rat. | The Journal of pharmacy and pharmacology 20010401 |
| Problems with ensuring a double blind. | The Journal of clinical psychiatry 20010401 |
| Effect of fluvoxamine and N-methyl-D-aspartate receptor antagonists on shock-induced depression in mice. | Indian journal of physiology and pharmacology 20010401 |
| Role of 5-HT(2a) and 5-HT(2B/2C) receptors in the behavioral interactions between serotonin and catecholamine reuptake inhibitors. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20010301 |
| Effect of fluvoxamine on the pharmacokinetics of mexiletine in healthy Japanese men. | Clinical pharmacology and therapeutics 20010301 |
| Alleviation of sleep disturbance and repetitive behavior by a selective serotonin re-uptake inhibitor in a boy with Asperger's syndrome. | Brain & development 20010301 |
| An open trial of light therapy for women with seasonal affective disorder and comorbid bulimia nervosa. | The Journal of clinical psychiatry 20010301 |
| Cytochrome P450 isoforms involved in melatonin metabolism in human liver microsomes. | European journal of clinical pharmacology 20010301 |
| Comparison of noradrenergic and serotonergic antidepressants in reducing immobility time in the tail suspension test. | Japanese journal of pharmacology 20010301 |
| Effects of fluvoxamine on morphine-induced inhibition of gastrointestinal transit, antinociception and hyperlocomotion in mice. | Neuroscience letters 20010216 |
| Psychopharmacologic treatment of adolescent depression. | Archives of psychiatric nursing 20010201 |
| Phenytoin intoxication induced by fluvoxamine. | Therapeutic drug monitoring 20010201 |
| Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial. | Journal of the American Academy of Child and Adolescent Psychiatry 20010201 |
| Fluvoxamine for psychosis in Alzheimer's disease. | The Journal of nervous and mental disease 20010201 |
| Restlessness related to SSRI withdrawal. | Psychiatry and clinical neurosciences 20010201 |
| Serum fluvoxamine levels in breastfed infants. | The Journal of clinical psychiatry 20010201 |
| Sexual dysfunction and fluvoxamine therapy. | The Journal of clinical psychiatry 20010201 |
| Priapism associated with polypharmacy. | The Journal of clinical psychiatry 20010201 |
| Delusionality and response to open-label fluvoxamine in body dysmorphic disorder. | The Journal of clinical psychiatry 20010201 |
| Using forecasting models to estimate the effects of changes in the composition of claims for selective serotonin reuptake inhibitors on expenditures. | Clinical therapeutics 20010201 |
| [The transfer of selective serotonin reuptake inhibitors to human milk]. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20010120 |
| Fluvoxamine inhibits the CYP2C9 catalyzed biotransformation of tolbutamide. | Clinical pharmacology and therapeutics 20010101 |
| Fluvoxamine approved for treating OCD in children. | Journal of psychosocial nursing and mental health services 20010101 |
| A case of adolescent body dysmorphic disorder treated with fluvoxamine. | Journal of child and adolescent psychopharmacology 20010101 |
| [Wernicke-Korsakoff syndrome: malignant tumour as triggering factor]. | Actas espanolas de psiquiatria 20010101 |
| SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study. | Clinical neuropharmacology 20010101 |
| Determination of moclobemide, paroxetine, and fluvoxamine in tablets by HPLC. | Acta poloniae pharmaceutica 20010101 |
| A subtype of auditory verbal hallucinations responds to fluvoxamine. | The Journal of neuropsychiatry and clinical neurosciences 20010101 |
| [Therapeutic action and efficiency of fevarin (fluvoxamine) in patients with non-psychotic anxious and apathic-adynamic depressions]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20010101 |
| The role of selective serotonin reuptake inhibitors in reducing alcohol consumption. | The Journal of clinical psychiatry 20010101 |
| Predictive value of amino acids in the treatment of major depression with fluvoxamine. | Neuropsychobiology 20010101 |
| Availability of learned helplessness test as a model of depression compared to a forced swimming test in rats. | Pharmacology 20010101 |
| Fluoxetine and fluvoxamine combined with individual cognitive-behaviour therapy in binge eating disorder: a one-year follow-up study. | Psychotherapy and psychosomatics 20010101 |
| Fluvoxamine as an adjunctive agent in schizophrenia. | CNS drug reviews 20010101 |
| A case of Korsakoff's syndrome improved by high doses of donepezil. | Alcohol and alcoholism (Oxford, Oxfordshire) 20010101 |
| Fluvoxamine: a review of its therapeutic potential in the management of anxiety disorders in children and adolescents. | Paediatric drugs 20010101 |
| Fluvoxamine treatment of a child with severe PDD: a single case study. | Psychiatry 20010101 |
| [Fluvoxamine (fevarin) in psychogenic depression]. | Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 20010101 |
| Seizure possibly associated with fluvoxamine. | The Annals of pharmacotherapy 20001101 |
| [Three cases of severe hyponatremia under taking selective serotonin reuptake inhibitor (SSRI)]. | Nihon Jinzo Gakkai shi 20001001 |
| Low dosage of levomepromazine did not increase plasma concentrations of fluvoxamine. | International clinical psychopharmacology 20000701 |
| Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor. | Biological psychiatry 20000501 |
| [Tourette's syndrome and antidepressant therapy: exacerbation of nervous tics with paroxetine]. | Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie 20000501 |
| Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level. | The Journal of neuroscience : the official journal of the Society for Neuroscience 19991201 |
| Movement disorders associated with fluvoxamine. | Journal of the American Academy of Child and Adolescent Psychiatry 19990801 |
| Incidence of sexual dysfunction in healthy volunteers on fluvoxamine therapy. | The Journal of clinical psychiatry 19990301 |
| Acute dystonia associated with fluvoxamine-metoclopramide. | The Annals of pharmacotherapy 19990301 |
| Extrapyramidal symptoms after addition of fluvoxamine to clozapine. | Journal of clinical psychopharmacology 19981201 |
| Sertraline in the treatment of clozapine-induced obsessive-compulsive behavior. | The American journal of psychiatry 19981101 |
| Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. | Journal of clinical psychopharmacology 19980801 |
| Fluvoxamine-induced erectile dysfunction responding to sildenafil. | Journal of sex & marital therapy 19980101 |
| Plasma prolactin response to d-fenfluramine in obsessive-compulsive patients before and after fluvoxamine treatment. | Biological psychiatry 19970801 |
| Prolactin response to d-fenfluramine in obsessive-compulsive patients, and outcome of fluvoxamine treatment. | The British journal of psychiatry : the journal of mental science 19970601 |
| The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons. | European journal of pharmacology 19970501 |
| Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy. | The Journal of clinical psychiatry 19970401 |
| A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients. | The Journal of clinical psychiatry 19970401 |
| Griseofulvin and fluvoxamine interactions with the metabolism of theophylline. | Therapeutic drug monitoring 19970201 |
| SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. | Journal of sex & marital therapy 19970101 |
| Non-response to citalopram in depressive patients: pharmacokinetic and clinical consequences of a fluvoxamine augmentation. | Psychopharmacology 19961201 |
| Treatment of fluvoxamine-induced anorgasmia with a partial drug holiday. | The American journal of psychiatry 19961001 |
| Serotonin reuptake inhibitor withdrawal. | Journal of clinical psychopharmacology 19961001 |
| A comparison of fluvoxamine and fluoxetine in the treatment of major depression. | Journal of clinical psychopharmacology 19961001 |
| Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reports. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 19960901 |
| Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpatients: a double-blind, multicentre study. The LUCIFER Group. | International clinical psychopharmacology 19960901 |
| Antidepressant-induced hypomania in obsessive-compulsive disorder. | International clinical psychopharmacology 19960901 |
| Fluvoxamine treatment in clozapine-induced obsessive-compulsive symptoms in schizophrenic patients. | Clinical neuropharmacology 19960801 |
| A double-blind comparative study of brofaromine and fluvoxamine in outpatients with panic disorder. | Journal of clinical psychopharmacology 19960801 |
| Fluvoxamine for premenstrual dysphoric disorder: a pilot study. | The Journal of clinical psychiatry 19960101 |
| [Sexual dysfunction secondary to SSRIs. A comparative analysis in 308 patients]. | Actas luso-espanolas de neurologia, psiquiatria y ciencias afines 19960101 |
| Severe myoclonus produced by fluvoxamine. | The Journal of clinical psychiatry 19951201 |
| Risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases. | The Journal of clinical psychiatry 19951101 |
| Cyproheptadine treatment of sexual dysfunction induced by serotonin reuptake inhibitors. | Clinical neuropharmacology 19950801 |
| Beneficial effect of low-dose mianserin on fluvoxamine-induced akathisia in an obsessive-compulsive patient. | International clinical psychopharmacology 19950601 |
| A seizure, and electroencephalographic signs of a lowered seizure threshold, associated with fluvoxamine treatment of obsessive-compulsive disorder. | Pharmacopsychiatry 19950501 |
| Overview of the pharmacokinetics of fluvoxamine. | Clinical pharmacokinetics 19950101 |
| Sinus bradycardia due to fluvoxamine overdose. | The British journal of psychiatry : the journal of mental science 19941001 |
| Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison. | The Journal of clinical psychiatry 19940701 |
| Emergence of symptoms of Tourette's syndrome during fluvoxamine treatment of obsessive-compulsive disorder. | The British journal of psychiatry : the journal of mental science 19940601 |
| Behavioral side effects in obsessive-compulsive patients treated with fluvoxamine: a clinical description. | Journal of clinical psychopharmacology 19940201 |
| Fluvoxamine-associated sexual dysfunction. | The Annals of pharmacotherapy 19940101 |
| Serotonin syndrome induced by fluvoxamine-lithium interaction. | Pharmacopsychiatry 19931101 |
| Emergence of depressive symptoms during treatment for panic disorder with specific 5-hydroxytryptophan reuptake inhibitors. | Acta psychiatrica Scandinavica 19931001 |
| Cardiovascular effects of imipramine, fluvoxamine, and placebo in depressed outpatients. | The Journal of clinical psychiatry 19930601 |
| The abrupt discontinuation of fluvoxamine in patients with panic disorder. | The Journal of clinical psychiatry 19930401 |
| Syndrome of inappropriate antidiuretic hormone secretion due to fluvoxamine therapy. | The British journal of clinical practice 19930101 |
| Seizures induced by combined levomepromazine-fluvoxamine treatment. | International clinical psychopharmacology 19930101 |
| Fluvoxamine can induce confusion in the elderly. | Journal of clinical psychopharmacology 19920801 |
| Extrapyramidal symptoms in a patient treated with fluvoxamine. | Journal of neurology, neurosurgery, and psychiatry 19920401 |
| [Fluvoxamine. Study of treatment effect on a group of 189 hospitalized patients with depression]. | L'Encephale 19920101 |
| Serotonin reuptake inhibitors, epilepsy and myoclonus. | The British journal of psychiatry : the journal of mental science 19910901 |
| Fluoxetine, fluvoxamine and extrapyramidal tract disorders. | International clinical psychopharmacology 19910101 |
| Fluvoxamine and lithium: an unusual interaction. | The British journal of psychiatry : the journal of mental science 19900201 |
| Some central effects of repeated treatment with fluvoxamine. | Polish journal of pharmacology and pharmacy 19890101 |
| Recovery from prolonged cerebral depression after fluvoxamine overdose. | British medical journal (Clinical research ed.) 19880625 |
| A double-blind placebo-controlled study of fluvoxamine and imipramine in depression. | The Journal of clinical psychiatry 19850301 |
| Comparison of the (pro)convulsive properties of fluvoxamine and clovoxamine with eight other antidepressants in an animal model. | Neuropsychobiology 19840101 |
| Effects of chronic treatment with antidepressants on aggressiveness induced by clonidine in mice. | Journal of neural transmission 19820101 |